{"gene":"SLC1A3","run_date":"2026-06-10T07:46:32","timeline":{"discoveries":[{"year":2005,"finding":"A heterozygous missense mutation in SLC1A3/EAAT1 causes markedly reduced glutamate uptake capacity. When co-expressed, the mutant EAAT1 specifically decreased wild-type EAAT1 activity (dominant-negative effect) but did not affect EAAT2 or EAAT3, indicating that mutant EAAT1 multimerizes specifically with wild-type EAAT1.","method":"Heterologous expression of mutant EAAT1, glutamate uptake assays, co-expression dominant-negative experiments","journal":"Neurology","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — in vitro uptake assay plus functional co-expression dominant-negative analysis, single lab but multiple orthogonal functional methods","pmids":["16116111"],"is_preprint":false},{"year":2003,"finding":"Surface expression and transport activity of EAAT1 are regulated by the ubiquitin ligase Nedd4-2 and serum/glucocorticoid-inducible kinases SGK1/SGK3 and protein kinase B (PKB). Nedd4-2 co-expression decreases EAAT1-mediated glutamate currents in Xenopus oocytes, an effect reversed by constitutively active SGK1, SGK3, or PKB. Site-directed mutagenesis identified phosphorylation site T482 in EAAT1 as important, with a phospho-mimetic T482D mutation increasing transport activity.","method":"Xenopus oocyte expression, electrophysiological recording of glutamate-induced currents, site-directed mutagenesis of EAAT1 and Nedd4-2","journal":"Journal of neurochemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution in oocytes with mutagenesis at multiple sites, single lab but multiple orthogonal methods (electrophysiology + mutagenesis)","pmids":["12911626"],"is_preprint":false},{"year":1999,"finding":"Glutamate stimulates its own uptake in astrocytes by rapidly increasing GLAST/EAAT1 expression at the cell surface (increased Vmax). This effect requires transporter activity (not receptor activation), is mimicked by the non-metabolizable substrate D-aspartate, does not occur in Na+-free medium, and is blocked by actin-disrupting agents cytochalasin B and D, indicating actin cytoskeleton-dependent trafficking of GLAST to the plasma membrane.","method":"Primary astrocyte cultures, glutamate uptake assays, biotinylation labeling of cell-surface proteins, pharmacological inhibition of actin polymerization","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Moderate — cell-surface biotinylation with functional uptake assay and pharmacological dissection, single lab, multiple orthogonal approaches","pmids":["10575016"],"is_preprint":false},{"year":2004,"finding":"Protein kinase C (PKC) activation by PMA acutely increases GLAST transport activity (~20%) in primary astrocytes but simultaneously reduces total and cell-surface GLAST immunoreactivity, indicating PKC modifies multiple intracellular epitopes of GLAST. Flag-tagged GLAST introduced by lentiviral vectors showed no change in flag immunoreactivity despite loss of GLAST antibody signal, demonstrating PKC causes post-translational modification of cytoplasmic epitopes rather than protein loss.","method":"Primary astrocyte cultures, phorbol ester treatment, glutamate transport assays, biotinylation of cell-surface proteins, lentiviral transduction of flag-tagged GLAST, PKC inhibitor bisindolylmaleimide II","journal":"Journal of neurochemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (functional transport + immunoreactivity + flag-epitope-tagged construct), single lab","pmids":["15569258"],"is_preprint":false},{"year":2017,"finding":"CaMKII constitutively regulates EAAT1 glutamate transport activity. Pharmacological inhibition of CaMKII reduces EAAT1-mediated [3H]-glutamate uptake in HEK293T cells. SPOTS peptide array and GST-fusion protein binding identified phosphorylation sites T26 and T37 in EAAT1's N-terminus as CaMKII substrates; a non-phosphorylatable T37A mutation diminished EAAT1-mediated glutamate uptake, identifying CaMKII-mediated phosphorylation at T37 as important for constitutive EAAT1 function.","method":"HEK293T heterologous expression, [3H]-glutamate uptake assay, SPOTS peptide array, GST-fusion protein biochemistry, site-directed mutagenesis (T37A), dominant-negative CaMKII overexpression","journal":"Journal of neurochemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with mutagenesis and direct substrate identification by peptide array, single lab but multiple orthogonal methods","pmids":["27889915"],"is_preprint":false},{"year":2009,"finding":"A C186S missense mutation in EAAT1/SLC1A3 causes a modest but significant reduction in glutamate uptake. This mutation segregates with episodic ataxia in a family, and the severity of EA6 symptoms correlates with the degree of glutamate transporter dysfunction.","method":"Direct sequencing of SLC1A3, glutamate uptake assay in cells expressing mutant EAAT1","journal":"Archives of neurology","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — functional uptake assay in heterologous expression, single lab, single method for functional analysis","pmids":["19139306"],"is_preprint":false},{"year":2017,"finding":"A T387P mutation in hEAAT1 identified in a migraine patient diminishes glutamate uptake rates and reduces EAAT1 surface membrane expression. Whole-cell patch clamp and fast substrate application showed that T387P specifically abolishes K+-bound retranslocation while preserving Na+-dependent anion currents, identifying impaired K+ binding as a novel mechanism of glutamate transport dysfunction.","method":"Heterologous expression in mammalian cells, whole-cell patch clamp, fast substrate application, Western blot/biochemical analysis of surface expression","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 1 / Moderate — electrophysiology with fast substrate application and biochemistry in a single rigorous study defining the mechanistic step (K+-retranslocation)","pmids":["29066757"],"is_preprint":false},{"year":2020,"finding":"Functional consequences of all known EA6-associated SLC1A3 mutations were compared: mutations cause a range of impairments including reduced transport function, impaired trafficking to the plasma membrane, and increased protein expression. Many mutations caused only slight individual changes, demonstrating that the cerebellum is highly sensitive to even partial EAAT1 dysfunction.","method":"Heterologous expression in mammalian cells, confocal imaging, Western blot, whole-cell patch clamp recording of transport and anion currents","journal":"Human mutation","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — systematic multiparameter functional characterization (electrophysiology + imaging + biochemistry) across multiple mutations in a single study","pmids":["32741053"],"is_preprint":false},{"year":2011,"finding":"A missense variant E219D in SLC1A3 increases glutamate uptake 1.66-fold and increases surface membrane EAAT1 protein 1.5-fold in HEK293 cells, demonstrating a gain-of-function effect on transport activity.","method":"[3H]-glutamate uptake assay and biotin-mediated membrane protein pull-down in transfected HEK293 cells","journal":"Psychiatric genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — two complementary methods (functional assay + surface biochemistry), single lab","pmids":["21233784"],"is_preprint":false},{"year":2007,"finding":"GLAST/EAAT1 activity directs FXYD2/gamma subunit of Na+,K+-ATPase to the astrocyte cell surface. When GLAST transport was blocked by TFB-TBOA, FXYD2 surface expression was reduced; siRNA knockdown of FXYD2 did not affect GLAST trafficking but abolished the glutamate uptake-dependent activation of Na+,K+-ATPase, demonstrating that GLAST activity drives FXYD2 trafficking which in turn modulates the sodium pump.","method":"Primary human fetal astrocyte cultures, glutamate uptake assays, biotinylation of surface proteins, siRNA knockdown of FXYD2, selective transporter inhibitor TFB-TBOA","journal":"Neurochemistry international","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple methods (biochemistry + siRNA knockdown + functional assays), single lab","pmids":["17316900"],"is_preprint":false},{"year":2006,"finding":"GLAST/EAAT1 expression in astrocytes is required to sustain normal spontaneous simple spike activity in zebrin-negative Purkinje cells by restricting NMDA receptor activation. In GLAST knockout mice, NMDA receptor blockade restored spontaneous PC activity and alleviated motor deficits, placing GLAST upstream of NMDA receptor overactivation in the cerebellum.","method":"GLAST knockout mice, in vivo electrophysiology (spontaneous Purkinje cell firing), pharmacological NMDA receptor blockade, behavioral motor testing","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout with electrophysiological phenotype rescue by pharmacological epistasis, replicated across multiple experimental approaches","pmids":["29741614"],"is_preprint":false},{"year":2006,"finding":"GLAST knockout mice show selective loss of Purkinje cells with low EAAT4 expression after global brain ischemia, demonstrating that GLAST protects against excitotoxic cerebellar damage in concert with EAAT4.","method":"GLAST and EAAT4 knockout mice, cardiac arrest model, histological quantification of Purkinje cell loss","journal":"Neuroscience research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis using two knockout models in vivo, single lab","pmids":["16647773"],"is_preprint":false},{"year":2010,"finding":"In GLAST-deficient mice (a model of normal tension glaucoma), ASK1 deficiency protects retinal ganglion cells and improves visual function. TNF-induced activation of p38 MAPK and iNOS production were suppressed in ASK1-deficient Müller glia, and TNF-induced RGC death was suppressed in ASK1-deficient RGCs, placing ASK1 downstream of GLAST-loss-induced oxidative/TNF stress leading to RGC apoptosis.","method":"GLAST-/- and ASK1-/- double knockout mice, multifocal electroretinography, histology, biochemical analysis of glutathione and malondialdehyde, cell death assays in primary Müller cells and RGCs","journal":"Cell death and differentiation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis with multiple outcome measures (visual function, histology, biochemistry), single lab","pmids":["20489729"],"is_preprint":false},{"year":1996,"finding":"Long-term treatment of astrocytes with L-glutamate or kainate (but not AMPA or tACPD) causes up-regulation of GLAST protein and increased D-aspartate uptake. The effect of glutamate is blocked by the kainate/AMPA receptor antagonist CNQX, and is mimicked by dbcAMP, indicating GLAST expression is regulated post-transcriptionally through kainate-type glutamate receptor signaling.","method":"Primary astrocyte cultures, D-[3H]aspartate uptake assays, Western blot quantification of GLAST protein, pharmacological receptor antagonists","journal":"Neuroreport","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional uptake assay combined with Western blot and pharmacological dissection, replicated with multiple agonists/antagonists, single lab","pmids":["9051792"],"is_preprint":false},{"year":2003,"finding":"Glutamate down-regulates GLAST mRNA levels and promoter activity in Bergmann glia via Ca2+-permeable AMPA receptors, with involvement of protein kinase C and the transcription factor c-Jun.","method":"Primary chick cerebellar Bergmann glia cultures, [3H]-D-aspartate uptake, promoter-reporter assays, RT-PCR, pharmacological inhibitors of AMPA receptors/PKC","journal":"Brain research. Molecular brain research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reporter assay plus mRNA analysis plus pharmacological dissection, single lab, multiple methods","pmids":["12824049"],"is_preprint":false},{"year":2007,"finding":"YY1 (Ying-Yang 1) transcription factor mediates glutamate-induced transcriptional repression of GLAST/EAAT1. Glutamate increases YY1 DNA binding; overexpression of YY1 reduces GLAST uptake, mRNA levels, and chglast promoter activity; a YY1 binding site in the GLAST promoter is required for the glutamate-dependent repression.","method":"Cultured chick cerebellar Bergmann glia, promoter-reporter assay with YY1 site mutations, [3H]-D-aspartate uptake, RT-PCR, EMSA for YY1 binding","journal":"Journal of neurochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — promoter reporter assay with mutation analysis plus functional uptake assay plus EMSA, single lab","pmids":["17394550"],"is_preprint":false},{"year":2015,"finding":"NF-κB is a positive transcriptional regulator of EAAT1/GLAST; mutation of NF-κB binding sites in the EAAT1 promoter decreases activity, and NF-κB inhibition reduces EAAT1 mRNA/protein levels and glutamate uptake. YY1 acts as a critical negative regulator, with HDAC co-repressors; manganese decreases EAAT1 expression via YY1, and HDAC inhibition reverses this. EGF increases EAAT1 expression via NF-κB.","method":"Human astrocyte H4 cells, promoter-reporter assays with NF-κB and YY1 site mutations, siRNA knockdown of YY1, NF-κB inhibition, RT-qPCR, Western blot, glutamate uptake assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — promoter mutagenesis, siRNA knockdown, pharmacological inhibition, and functional uptake assay in a single study with multiple orthogonal methods","pmids":["26269591"],"is_preprint":false},{"year":2003,"finding":"The human EAAT1 promoter core element (−57 to +20 bp) is TATA-box-less and depends on a GC-box at −52/−39 bound by Sp1/Sp3 and an E-box near the TSS bound by USF1. cAMP and EGF increase EAAT1 promoter activity and mRNA/glutamate uptake in human astrocytes; TNF-α reduces both promoter activity and EAAT1 mRNA expression.","method":"Cloning and transfection of human EAAT1 promoter deletion constructs, EMSA, supershift and competition assays, RT-PCR, glutamate uptake assay in primary human astrocytes","journal":"Journal of neurochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — promoter deletion/mutation analysis with EMSA identification of binding proteins plus functional assays, single lab","pmids":["14713304"],"is_preprint":false},{"year":2011,"finding":"GLAST/EAAT1 transport activity triggers mTOR phosphorylation (Ser2448) and downstream signaling in Bergmann glia. D-aspartate and other transported substrates (but not non-transported ligands) activate a cascade involving Ca2+ influx, PI3K, and PKB, leading to increased AP-1 DNA binding and upregulation of AP-1-driven transcription.","method":"Primary chick cerebellar Bergmann glia, D-aspartate and transporter ligand treatments, mTOR phosphorylation assays, pharmacological inhibitors, AP-1 reporter gene assays","journal":"Neurochemistry international","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological dissection with reporter assay and phosphorylation analysis, single lab, multiple methods but all in one system","pmids":["21856347"],"is_preprint":false},{"year":2007,"finding":"GDNF upregulates GLAST-1 expression via phosphoinositide-3 kinase (PI3K) and Src kinase activity; neurturin upregulates GLAST-1 via PI3K alone. RNA interference demonstrating that GLAST-1 upregulation by GDNF and neurturin is required for their neuroprotective rescue of retinal ganglion cells after optic nerve transection, establishing GLAST-1 upregulation as an indirect neuroprotective mechanism.","method":"Adult rat retina, GDNF/NTN intravitreal application, PI3K and Src kinase inhibitors, siRNA knockdown of GLAST-1, RGC survival counting after optic nerve transection","journal":"Cell death and differentiation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pathway inhibitors plus RNAi with in vivo cell survival readout, single lab","pmids":["18064044"],"is_preprint":false},{"year":2010,"finding":"P2X7 receptor activation by ATP decreases GLAST mRNA stability in astrocytes via a Ca2+-dependent PI3K–PLCγ–IP3R–CaMKII–PKC signaling cascade. This mechanism was demonstrated by P2X7R blockade, P2X7R siRNA knockdown, promoter deletion assays, and RNA decay assays.","method":"Primary rat cortical astrocytes, ATP and BzATP treatment, P2X7R antagonist (oxATP) and shRNA knockdown, GLAST promoter deletion assays, RNA decay assays, Ca2+ chelation, pharmacological pathway inhibitors","journal":"Journal of neurochemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (RNAi, pharmacology, promoter and RNA stability assays) dissecting a specific signaling pathway, single lab","pmids":["20070863"],"is_preprint":false},{"year":2014,"finding":"GSK3β differentially regulates GLT-1 and GLAST: in heterologous expression systems (COS-7 cells and Xenopus oocytes), GSK3β stimulates GLT-1 activity and reduces GLAST activity, with corresponding changes in plasma membrane amounts. GSK3β increases phosphorylation of GLAST while decreasing that of GLT-1. Pharmacological GSK3β inhibition in primary rat cortical cultures also differentially modulates the two transporters.","method":"COS-7 cell and Xenopus oocyte heterologous expression, transporter activity assays, plasma membrane quantification, 32Pi incorporation (phosphorylation), GSK3β inhibitors and dominant-negative kinase, primary rat cortical astrocyte cultures","journal":"Neurochemistry international","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — two heterologous expression systems plus primary cultures with functional and biochemical endpoints, single lab","pmids":["25454285"],"is_preprint":false},{"year":2018,"finding":"p53 promotes expression of SLC1A3, an aspartate/glutamate transporter, under glutamine deprivation. SLC1A3 expression maintains electron transport chain and TCA cycle activity and supports de novo glutamate, glutamine, and nucleotide synthesis to rescue cell viability. SLC1A3 depletion retards tumor growth in vitro and in vivo, establishing SLC1A3 as a mediator of p53-dependent metabolic adaptation.","method":"Cell viability assays, metabolic flux analysis (isotope tracing), xenograft tumor growth, SLC1A3 knockdown and overexpression, p53 reporter and ChIP-inferred transcriptional regulation","journal":"Cell metabolism","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (metabolic flux, in vivo xenograft, gain- and loss-of-function) in a single study replicated across cell lines and in vivo","pmids":["30122553"],"is_preprint":false},{"year":2019,"finding":"SLC1A3 mediates aspartate/glutamate uptake that fuels ASNase resistance in solid tumor cells by supporting TCA cycle, urea cycle, nucleotide biosynthesis, energy production, redox homeostasis, and lipid biosynthesis. In vivo, SLC1A3 expression promoted tumor development and metastasis while negating ASNase suppressive effects.","method":"Functional genetic screen, siRNA/shRNA knockdown, cell cycle and apoptosis assays, metabolic profiling, xenograft tumor models in mice","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — functional genetic screen followed by mechanistic validation with multiple metabolic endpoints and in vivo models, single lab but highly replicated methodology","pmids":["31523835"],"is_preprint":false},{"year":2010,"finding":"In Drosophila, Eaat1 (ortholog of mammalian GLAST/EAAT1) expression in CNS glia is regulated by the glycosyltransferase Fringe via Delta-Notch ligand-receptor signaling from neurons to glia during embryogenesis. Loss-of-function Eaat1 mutations cause failure of rhythmic peristaltic crawling in larvae, associated with altered synaptic current frequency, amplitude, and kinetics in motor neurons, establishing Eaat1 as essential for glutamate homeostasis in CNS circuits controlling locomotion.","method":"Drosophila genetics (loss-of-function mutations, Fringe/Notch pathway manipulation), electrophysiology of motor neuron synaptic currents, behavioral locomotion assays, postembryonic inactivation experiments","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic loss-of-function with electrophysiological and behavioral readouts plus pathway epistasis (Fringe-Notch-Eaat1), replicated across multiple experimental approaches","pmids":["20980602"],"is_preprint":false},{"year":2018,"finding":"During hair growth, SLC1A3 is transiently upregulated in proliferating stem/progenitor cells in hair follicle bulge, sebaceous gland, and interfollicular epidermis. Deletion of slc1a3 delays hair follicle anagen entry and uncouples IFE and SG expansion from the hair cycle. Modulation of metabotropic glutamate receptor 5 (mGluR5) activity mimics the effects of SLC1A3 deletion or inhibition, suggesting SLC1A3 acts upstream of mGluR5 signaling to coordinate stem/progenitor cell activation across skin niches.","method":"Transgenic fate-mapping in mice, slc1a3 conditional knockout, BrdU/Ki67 proliferation assays, pharmacological mGluR5 modulation, hair cycle staging","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional knockout with fate mapping and pharmacological epistasis, multiple niche readouts, single lab but rigorous multi-method design","pmids":["29615452"],"is_preprint":false},{"year":2007,"finding":"Amitriptyline induces trafficking of GLAST and GLT-1 from cytosol onto the glial cell surface in morphine-tolerant rats by inhibiting phospho-PKA and PKC (PKCα, PKCβII, PKCγ) expression; the same PKA/PKC inhibitors alone also induced GLAST/GLT-1 trafficking. This trafficking correlates with suppression of morphine-evoked EAA (glutamate, aspartate) release in spinal CSF.","method":"Intrathecal morphine-tolerant rat model, antinociception dose-response curves, PKA/PKC inhibitor treatments, synaptosomal surface biotinylation, Western blot of GLAST/GLT-1 cytosol vs. membrane, microdialysis/amino acid measurement in CSF","journal":"Pain","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — surface biotinylation plus in vivo pharmacological pathway dissection with functional CSF amino acid readout, single lab","pmids":["17346885"],"is_preprint":false},{"year":2002,"finding":"GLAST-1 protein localizes to the plasma membrane of osteocytes in a glutamate-concentration-dependent manner: low extracellular glutamate redistributes GLAST-1-GFP to intracellular vesicles, while a splice variant (GLAST-1a, lacking exon 3) constitutively localizes to internal vesicles and does not traffic to the plasma membrane.","method":"Transfection of GFP-tagged GLAST-1 and GLAST-1a into MLO-Y4 osteocytes, fluorescence microscopy, RT-PCR","journal":"Biochemical Society transactions","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single imaging method in a single report, limited functional validation","pmids":["12440940"],"is_preprint":false},{"year":2019,"finding":"In glioblastoma (GBM) stem-like cells, GLAST is expressed but cells release rather than take up glutamate due to lack of Na+/K+-ATPase. Overexpression of Na+/K+-ATPase in GBM stem-like cells restores glutamate uptake and induces apoptosis, demonstrating that GLAST transport direction in tumor cells depends on Na+/K+-ATPase activity. Intratumoral injection of GLAST inhibitor UCPH-101 significantly increased survival of glioma-bearing mice.","method":"GBM stem cell cultures, Na+/K+-ATPase overexpression, glutamate release/uptake assays, apoptosis assays, MR spectroscopy, mouse xenograft with UCPH-101 treatment","journal":"International journal of cancer","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain-of-function rescue experiment plus in vivo pharmacological inhibition, single lab, multiple methods","pmids":["30418668"],"is_preprint":false},{"year":2006,"finding":"GLAST/EAAT1 regulates cell-surface expression of the neutral amino acid transporter ASCT2 in human fetal astrocytes: glutamate transported by GLAST is converted to glutamine by glutamine synthetase (GS), and this intracellular glutamine is a more potent inducer of ASCT2 trafficking to the cell surface than direct ASCT2 substrates. siRNA knockdown of GS abolished the glutamate-dependent ASCT2 trafficking effect.","method":"Primary human fetal astrocyte cultures, cAMP-induced differentiation, siRNA knockdown of GS, biotinylation of surface proteins, fluorescence microscopy, TFB-TBOA transporter block","journal":"Neurochemistry international","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA knockdown plus surface biotinylation and pharmacological transport block, single lab","pmids":["16516348"],"is_preprint":false},{"year":2021,"finding":"Chronic optogenetic activation of Bergmann glia reduces EAAT1 function, prolongs excitatory postsynaptic currents in Purkinje cells, and causes astroglyosis and Purkinje cell atrophy—phenotypes identical to those caused by expression of polyglutamine-expanded ataxin-1 in Bergmann glia, establishing that excessive glutamate signaling from EAAT1 dysfunction is a driver of SCA1-like cerebellar neurodegeneration.","method":"Mouse Bergmann glia-targeted optogenetics (ChR2), patch clamp recordings of EPSC kinetics in Purkinje cells, histological analysis of astroglyosis and Purkinje cell atrophy, comparison with ataxin-1[Q85] and ataxin-1[Q154] knock-in mouse models","journal":"Neurobiology of disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — three independent models (optogenetic, transgenic overexpression, knock-in) with electrophysiological readout, single lab","pmids":["33753288"],"is_preprint":false},{"year":1996,"finding":"The mouse Slc1a3 gene spans >56 kb with 10 exons, maps to chromosome 15A2, and contains a CCAAT box and GC box (but no TATA box) in its promoter. A 4-kb 5'-flanking region drives luciferase expression in COS-1 cells; deletion to 619 bp causes a marked decrease, identifying the CCAAT box at −200 as necessary for expression.","method":"Genomic library screening, restriction mapping, primer extension, promoter-luciferase reporter assays in COS-1 cells, in situ hybridization chromosomal localization","journal":"Genomics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — promoter deletion reporter assays with chromosomal mapping, single lab, multiple methods","pmids":["8661010"],"is_preprint":false}],"current_model":"SLC1A3/EAAT1/GLAST is a Na+-K+-H+-coupled high-affinity glutamate/aspartate transporter primarily expressed in astrocytes and Bergmann glia that clears glutamate from the synaptic cleft; its transport activity and plasma membrane abundance are regulated by substrate-induced actin-dependent trafficking, PKC-mediated epitope modification, CaMKII-dependent phosphorylation at N-terminal residues (especially T37), SGK/PKB-Nedd4-2-dependent ubiquitination, and GSK3β-mediated phosphorylation; transcription is positively driven by NF-κB (Sp1/Sp3 and USF1 at the core promoter) and negatively by YY1 (with HDAC co-repressors), with upstream signals including glutamate itself (via AMPA receptors), p53, GDNF/neurturin (via PI3K/Src), estrogen, and ATP (via P2X7R/PI3K/Ca2+); disease-associated mutations cause loss-of-function (reduced glutamate uptake and/or impaired K+-retranslocation), dominant-negative multimerization, or altered trafficking; beyond classical neurotransmitter clearance, SLC1A3 activity drives FXYD2/Na+,K+-ATPase surface expression, triggers mTOR/PI3K/AP-1 signaling in glia, fuels aspartate/glutamate-dependent TCA cycle and biosynthetic metabolism in cancer cells under nutrient stress, and coordinates epithelial stem/progenitor cell activation across skin niches via mGluR5 signaling."},"narrative":{"mechanistic_narrative":"SLC1A3 (EAAT1/GLAST) is a Na+-coupled high-affinity glutamate/aspartate transporter that clears synaptic glutamate in astrocytes and Bergmann glia, sustaining normal Purkinje cell firing and protecting neurons from excitotoxicity [PMID:29741614, PMID:16647773]. Transport requires a defined ion-coupling cycle, and a migraine-associated T387P mutation selectively abolishes the K+-bound retranslocation step while preserving Na+-dependent anion currents, defining impaired K+ binding as a discrete transport defect [PMID:29066757]. Surface abundance and activity are set by an extensive regulatory network: substrate-driven, actin-dependent trafficking to the plasma membrane [PMID:10575016]; CaMKII phosphorylation of N-terminal T26/T37 [PMID:27889915]; SGK1/SGK3/PKB-antagonized, Nedd4-2-dependent ubiquitination acting through residue T482 [PMID:12911626]; PKC-mediated modification of cytoplasmic epitopes [PMID:15569258]; and GSK3β-mediated phosphorylation that suppresses GLAST while stimulating GLT-1 [PMID:25454285]. Transcription is bidirectionally controlled at a TATA-less core promoter, positively by NF-κB acting with Sp1/Sp3 and USF1 and negatively by YY1 with HDAC co-repressors, integrating glutamate, cytokine, and growth-factor signals [PMID:26269591, PMID:14713304]. Beyond transport, GLAST activity orchestrates downstream membrane and signaling events—directing FXYD2 to the surface to modulate Na+,K+-ATPase [PMID:17316900] and triggering Ca2+/PI3K/PKB/mTOR-AP-1 signaling in glia [PMID:21856347]—and is co-opted in cancer, where p53 induces SLC1A3 to fuel aspartate/glutamate-dependent TCA cycle and biosynthetic metabolism under nutrient stress [PMID:30122553, PMID:31523835]. SLC1A3 also coordinates epithelial stem/progenitor activation across skin niches upstream of mGluR5 [PMID:29615452]. Loss-of-function, dominant-negative, and gain-of-function missense mutations in SLC1A3 cause episodic ataxia type 6 through partial transport, trafficking, or expression defects to which the cerebellum is acutely sensitive [PMID:16116111, PMID:19139306, PMID:32741053].","teleology":[{"year":1996,"claim":"Establishing the genomic and promoter architecture of Slc1a3 framed how transcription of the transporter could be controlled.","evidence":"Genomic library screening, promoter-luciferase reporters and chromosomal mapping in COS-1 cells","pmids":["8661010"],"confidence":"Medium","gaps":["Did not identify the trans-acting factors binding the CCAAT/GC boxes","Mouse promoter only; human core element unresolved at this stage"]},{"year":1996,"claim":"Linking glutamate exposure to up-regulation of GLAST protein showed the transporter is dynamically tuned to substrate load via kainate-type receptor signaling.","evidence":"Primary astrocyte uptake assays, Western blot and pharmacological receptor antagonists","pmids":["9051792"],"confidence":"Medium","gaps":["Distinguished post-transcriptional regulation but did not define the molecular trafficking step","Receptor coupling to transporter expression left at the pharmacological level"]},{"year":1999,"claim":"Demonstrating that substrate transport itself drives rapid actin-dependent surface delivery of GLAST established a feed-forward mechanism for matching uptake capacity to glutamate availability.","evidence":"Astrocyte biotinylation, uptake assays and actin-disruption pharmacology","pmids":["10575016"],"confidence":"High","gaps":["Trafficking machinery/adaptors mediating surface delivery not identified","Whether this acute mechanism applies in vivo untested"]},{"year":2003,"claim":"Identifying the human EAAT1 core promoter and its Sp1/Sp3 and USF1 factors, and the SGK/PKB-Nedd4-2-T482 ubiquitination axis, defined parallel transcriptional and post-translational set-points for transporter abundance.","evidence":"Promoter deletion/EMSA in human astrocytes; Xenopus oocyte electrophysiology with Nedd4-2/SGK/PKB co-expression and T482 mutagenesis","pmids":["14713304","12911626"],"confidence":"Medium","gaps":["Whether T482 is directly phosphorylated by SGK/PKB not shown","Promoter factor interactions not tested in vivo"]},{"year":2003,"claim":"Showing glutamate represses GLAST transcription through Ca2+-permeable AMPA receptors, PKC and c-Jun revealed a negative arm balancing substrate-induced up-regulation.","evidence":"Bergmann glia promoter-reporter, uptake and RT-PCR with AMPA/PKC inhibitors","pmids":["12824049"],"confidence":"Medium","gaps":["Direct promoter element for c-Jun not mapped here","Reconciliation with substrate-induced up-regulation not addressed"]},{"year":2004,"claim":"Distinguishing PKC-induced epitope modification from protein loss clarified that acute PKC signaling modifies cytoplasmic regions of GLAST rather than degrading it.","evidence":"Astrocyte transport assays, surface biotinylation and flag-tagged GLAST with PKC inhibitor","pmids":["15569258"],"confidence":"High","gaps":["Specific modified residues not identified","Functional consequence of epitope modification beyond a modest activity change unclear"]},{"year":2005,"claim":"The first disease mutation showed EAAT1 loss-of-function and a paralog-specific dominant-negative effect, indicating selective EAAT1-EAAT1 multimerization underlies dominant inheritance.","evidence":"Heterologous expression, uptake assays and co-expression dominant-negative tests","pmids":["16116111"],"confidence":"High","gaps":["Structural basis of selective multimerization not resolved","In vivo neuronal consequence not modeled"]},{"year":2006,"claim":"Genetic deletion in mice placed GLAST upstream of NMDA receptor overactivation in cerebellar circuits and demonstrated its protective role against excitotoxic Purkinje cell loss.","evidence":"GLAST and EAAT4 knockout mice with in vivo electrophysiology, NMDA blockade epistasis and ischemia histology","pmids":["29741614","16647773"],"confidence":"High","gaps":["Cell-autonomous vs. circuit-level contributions not fully separated","Mechanism of EAAT4 cooperativity unresolved"]},{"year":2007,"claim":"Discovering that GLAST activity directs FXYD2 and ASCT2 surface trafficking, and that GDNF/neurturin up-regulate GLAST via PI3K/Src, expanded its role from transporter to organizer of downstream membrane transport and neuroprotection.","evidence":"Human fetal astrocyte biotinylation with FXYD2/GS siRNA and transporter block; rat retina with PI3K/Src inhibitors, GLAST siRNA and RGC survival","pmids":["17316900","16516348","18064044"],"confidence":"Medium","gaps":["Molecular link coupling GLAST transport to FXYD2/ASCT2 trafficking unknown","Glutamine-sensing mechanism for ASCT2 induction not defined"]},{"year":2007,"claim":"YY1 was identified as the transcription factor mediating glutamate-induced GLAST repression, providing the trans-acting basis for the negative regulatory arm.","evidence":"Bergmann glia promoter-reporter with YY1 site mutation, uptake, RT-PCR and EMSA","pmids":["17394550"],"confidence":"Medium","gaps":["Co-repressor partners not yet defined in this study","Signaling link from glutamate to YY1 binding incomplete"]},{"year":2010,"claim":"Defining the P2X7R-driven Ca2+/PI3K-PLCγ-CaMKII-PKC cascade that destabilizes GLAST mRNA, and the ASK1-dependent stress pathway downstream of GLAST loss, connected extracellular ATP and oxidative/TNF stress to transporter levels and neuronal survival.","evidence":"Astrocyte P2X7R knockdown, promoter and RNA-decay assays; GLAST/ASK1 double-knockout glaucoma model","pmids":["20070863","20489729"],"confidence":"High","gaps":["cis-element conferring mRNA instability not mapped","ASK1 pathway placement is epistatic, not biochemically direct on GLAST"]},{"year":2010,"claim":"The Drosophila ortholog established Eaat1 as essential for glutamate homeostasis in locomotor circuits and revealed Fringe/Delta-Notch control of its glial expression developmentally.","evidence":"Fly loss-of-function genetics, motor neuron electrophysiology, locomotion assays and Notch pathway epistasis","pmids":["20980602"],"confidence":"High","gaps":["Conservation of Notch-driven regulation in mammals untested","Mapping to specific synaptic transmitter clearance steps incomplete"]},{"year":2011,"claim":"Showing transport-dependent activation of Ca2+/PI3K/PKB-mTOR-AP-1 signaling cast GLAST as a signaling node, not merely a transporter, in glia.","evidence":"Bergmann glia substrate treatments with mTOR phosphorylation, pathway inhibitors and AP-1 reporters","pmids":["21856347"],"confidence":"Medium","gaps":["How transport flux couples to Ca2+/PI3K signaling mechanistically unknown","Downstream AP-1 target genes not identified"]},{"year":2014,"claim":"Demonstrating that GSK3β oppositely regulates GLAST and GLT-1 through differential phosphorylation revealed transporter-selective kinase control.","evidence":"COS-7/oocyte expression with activity, surface and 32Pi phosphorylation assays plus GSK3β inhibitors","pmids":["25454285"],"confidence":"Medium","gaps":["GSK3β phosphosites on GLAST not mapped","Direct vs. indirect phosphorylation not distinguished"]},{"year":2015,"claim":"Integrating NF-κB as a positive and YY1/HDAC as a negative promoter regulator, with manganese and EGF inputs, unified the bidirectional transcriptional control of EAAT1.","evidence":"Human astrocyte promoter mutagenesis, YY1 siRNA, NF-κB inhibition, RT-qPCR and uptake assays","pmids":["26269591"],"confidence":"High","gaps":["Cooperativity/competition between NF-κB and YY1 at the promoter not resolved","In vivo relevance of manganese-YY1 axis untested here"]},{"year":2017,"claim":"Identifying CaMKII phosphorylation of N-terminal T26/T37 as required for constitutive transport, and a migraine T387P mutation that abolishes K+-retranslocation, refined both the regulatory and ion-coupling mechanisms of EAAT1.","evidence":"HEK293T uptake with peptide arrays/GST binding and T37A mutagenesis; mammalian patch clamp with fast substrate application and surface biochemistry","pmids":["27889915","29066757"],"confidence":"High","gaps":["Whether T37 phosphorylation regulates trafficking or intrinsic turnover unclear","Structural basis of K+ binding defect not solved"]},{"year":2018,"claim":"Linking p53-induced SLC1A3 to maintenance of TCA cycle flux and biosynthesis under glutamine deprivation, and an upstream role in mGluR5-coordinated skin stem-cell activation, extended its function into tumor metabolic adaptation and tissue regeneration.","evidence":"Isotope flux, xenograft growth with SLC1A3 knockdown/overexpression; mouse conditional knockout, fate-mapping and mGluR5 pharmacology","pmids":["30122553","29615452"],"confidence":"High","gaps":["Direct p53 binding to the SLC1A3 locus inferred, not fully demonstrated","Mechanism coupling SLC1A3 transport to mGluR5 signaling undefined"]},{"year":2019,"claim":"Showing SLC1A3 drives aspartate/glutamate uptake supporting asparaginase resistance, and that its transport direction in glioblastoma stem cells depends on Na+/K+-ATPase, established context-dependent transporter directionality as a therapeutic vulnerability.","evidence":"Functional genetic screen with metabolic profiling and xenografts; GBM stem cells with Na+/K+-ATPase rescue and UCPH-101 inhibition in vivo","pmids":["31523835","30418668"],"confidence":"Medium","gaps":["Tumor-type generality of the directionality switch unclear","Whether transport reversal is exploitable across cancers untested"]},{"year":2020,"claim":"Systematic comparison of EA6 mutations showed they produce graded transport, trafficking, and expression defects, explaining the cerebellum's sensitivity to even partial EAAT1 dysfunction.","evidence":"Heterologous expression with confocal imaging, Western blot and patch clamp across mutations","pmids":["32741053"],"confidence":"High","gaps":["Genotype-phenotype severity mapping incomplete","In vivo modeling of individual variants lacking"]},{"year":2021,"claim":"Linking reduced EAAT1 function to prolonged Purkinje cell EPSCs and SCA1-like neurodegeneration cast transporter dysfunction as an active driver of cerebellar pathology.","evidence":"Bergmann glia optogenetics with Purkinje cell patch clamp and ataxin-1 knock-in comparison","pmids":["33753288"],"confidence":"Medium","gaps":["Direct biochemical mechanism reducing EAAT1 function during optogenetic activation unresolved","Causal link to human SCA1 inferential"]},{"year":null,"claim":"How the diverse phosphorylation, ubiquitination, and trafficking inputs are integrated structurally on a single transporter, and how transport directionality is switched between clearance and release across tissues, remain unresolved.","evidence":"","pmids":[],"confidence":"Low","gaps":["No structural model integrating regulatory phosphosites","Mechanism determining net uptake vs. efflux in tumor vs. glia undefined","Direct kinase-substrate relationships for several modifications unproven"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[0,2,6,22,23]},{"term_id":"GO:0140104","term_label":"molecular carrier activity","supporting_discovery_ids":[22,23]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[2,3,9,27]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[27]}],"pathway":[{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[10,24]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[22,23]},{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[2,6]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[16,17]}],"complexes":[],"partners":["NEDD4-2","SGK1","PKB","CAMK2","GSK3B","FXYD2","TP53"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P43003","full_name":"Excitatory amino acid transporter 1","aliases":["Sodium-dependent glutamate/aspartate transporter 1","GLAST-1","Solute carrier family 1 member 3"],"length_aa":542,"mass_kda":59.6,"function":"Sodium-dependent, high-affinity amino acid transporter that mediates the uptake of L-glutamate and also L-aspartate and D-aspartate (PubMed:20477940, PubMed:26690923, PubMed:28032905, PubMed:28424515, PubMed:7521911, PubMed:8123008). Functions as a symporter that transports one amino acid molecule together with two or three Na(+) ions and one proton, in parallel with the counter-transport of one K(+) ion (PubMed:20477940). Mediates Cl(-) flux that is not coupled to amino acid transport; this avoids the accumulation of negative charges due to aspartate and Na(+) symport (PubMed:20477940). Plays a redundant role in the rapid removal of released glutamate from the synaptic cleft, which is essential for terminating the postsynaptic action of glutamate (By similarity)","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/P43003/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/SLC1A3","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000079215","cell_line_id":"CID001317","localizations":[{"compartment":"membrane","grade":3},{"compartment":"vesicles","grade":3}],"interactors":[{"gene":"ABI1","stoichiometry":4.0},{"gene":"CYFIP1","stoichiometry":0.2},{"gene":"SNX9","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/target/CID001317","total_profiled":1310},"omim":[{"mim_id":"617502","title":"WD REPEAT-CONTAINING PROTEIN 41; WDR41","url":"https://www.omim.org/entry/617502"},{"mim_id":"615770","title":"ATRIAL FIBRILLATION, FAMILIAL, 15; ATFB15","url":"https://www.omim.org/entry/615770"},{"mim_id":"613174","title":"CHROMOSOME 5p13 DUPLICATION SYNDROME","url":"https://www.omim.org/entry/613174"},{"mim_id":"612656","title":"EPISODIC ATAXIA, TYPE 6; EA6","url":"https://www.omim.org/entry/612656"},{"mim_id":"610323","title":"METADHERIN; MTDH","url":"https://www.omim.org/entry/610323"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoli","reliability":"Approved"},{"location":"Vesicles","reliability":"Approved"}],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"brain","ntpm":527.4},{"tissue":"retina","ntpm":204.7}],"url":"https://www.proteinatlas.org/search/SLC1A3"},"hgnc":{"alias_symbol":["EAAT1","GLAST","EA6","GLAST1","GLAST-1"],"prev_symbol":[]},"alphafold":{"accession":"P43003","domains":[{"cath_id":"1.10.3860.10","chopping":"40-187_240-514","consensus_level":"medium","plddt":87.8903,"start":40,"end":514},{"cath_id":"-","chopping":"196-234","consensus_level":"high","plddt":62.9103,"start":196,"end":234}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P43003","model_url":"https://alphafold.ebi.ac.uk/files/AF-P43003-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P43003-F1-predicted_aligned_error_v6.png","plddt_mean":82.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SLC1A3","jax_strain_url":"https://www.jax.org/strain/search?query=SLC1A3"},"sequence":{"accession":"P43003","fasta_url":"https://rest.uniprot.org/uniprotkb/P43003.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P43003/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P43003"}},"corpus_meta":[{"pmid":"30851309","id":"PMC_30851309","title":"The role of astrocytic glutamate transporters GLT-1 and GLAST in neurological disorders: Potential targets for neurotherapeutics.","date":"2019","source":"Neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/30851309","citation_count":362,"is_preprint":false},{"pmid":"9364068","id":"PMC_9364068","title":"Glutamate transporter GLAST is expressed in the radial glia-astrocyte lineage of developing mouse spinal cord.","date":"1997","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/9364068","citation_count":323,"is_preprint":false},{"pmid":"16116111","id":"PMC_16116111","title":"Mutation in the glutamate transporter EAAT1 causes episodic ataxia, hemiplegia, and seizures.","date":"2005","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/16116111","citation_count":272,"is_preprint":false},{"pmid":"10575016","id":"PMC_10575016","title":"Glutamate induces rapid upregulation of astrocyte glutamate transport and cell-surface expression of GLAST.","date":"1999","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/10575016","citation_count":261,"is_preprint":false},{"pmid":"8531222","id":"PMC_8531222","title":"Coincidence of L-glutamate/L-aspartate transporter (GLAST) and glutamine synthetase (GS) immunoreactions in retinal glia: evidence for coupling of GLAST and GS in transmitter clearance.","date":"1995","source":"Journal of neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/8531222","citation_count":215,"is_preprint":false},{"pmid":"9375696","id":"PMC_9375696","title":"Neuronal soluble factors differentially regulate the expression of the GLT1 and GLAST glutamate transporters in cultured astroglia.","date":"1997","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9375696","citation_count":198,"is_preprint":false},{"pmid":"30122553","id":"PMC_30122553","title":"A Role for p53 in the Adaptation to Glutamine Starvation through the Expression of SLC1A3.","date":"2018","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/30122553","citation_count":196,"is_preprint":false},{"pmid":"9572288","id":"PMC_9572288","title":"Traumatic brain injury down-regulates glial glutamate transporter (GLT-1 and GLAST) proteins in rat brain.","date":"1998","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9572288","citation_count":176,"is_preprint":false},{"pmid":"10936189","id":"PMC_10936189","title":"The GLT-1 and GLAST glutamate transporters are expressed on morphologically distinct astrocytes and regulated by neuronal activity in primary hippocampal cocultures.","date":"2000","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10936189","citation_count":159,"is_preprint":false},{"pmid":"15896872","id":"PMC_15896872","title":"Regulation of glutamate transporter GLAST and GLT-1 expression in astrocytes by estrogen.","date":"2005","source":"Brain research. Molecular brain research","url":"https://pubmed.ncbi.nlm.nih.gov/15896872","citation_count":154,"is_preprint":false},{"pmid":"9051792","id":"PMC_9051792","title":"Glutamate receptor agonists up-regulate glutamate transporter GLAST in astrocytes.","date":"1996","source":"Neuroreport","url":"https://pubmed.ncbi.nlm.nih.gov/9051792","citation_count":145,"is_preprint":false},{"pmid":"19078949","id":"PMC_19078949","title":"Assessment of glutamate transporter GLAST (EAAT1)-deficient mice for phenotypes relevant to the negative and executive/cognitive symptoms of schizophrenia.","date":"2008","source":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/19078949","citation_count":143,"is_preprint":false},{"pmid":"11826152","id":"PMC_11826152","title":"Aberrant expression of the glutamate transporter excitatory amino acid transporter 1 (EAAT1) in Alzheimer's disease.","date":"2002","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/11826152","citation_count":106,"is_preprint":false},{"pmid":"19323820","id":"PMC_19323820","title":"Plasticity in expression of the glutamate transporters GLT-1 and GLAST in spinal dorsal horn glial cells following partial sciatic nerve ligation.","date":"2009","source":"Molecular pain","url":"https://pubmed.ncbi.nlm.nih.gov/19323820","citation_count":104,"is_preprint":false},{"pmid":"29988908","id":"PMC_29988908","title":"Glutamate transporters, EAAT1 and EAAT2, are potentially important in the pathophysiology and treatment of schizophrenia and affective disorders.","date":"2018","source":"World journal of psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/29988908","citation_count":103,"is_preprint":false},{"pmid":"12911626","id":"PMC_12911626","title":"Regulation of the glutamate transporter EAAT1 by the ubiquitin ligase Nedd4-2 and the serum and glucocorticoid-inducible kinase isoforms SGK1/3 and protein kinase B.","date":"2003","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12911626","citation_count":96,"is_preprint":false},{"pmid":"23554226","id":"PMC_23554226","title":"In vivo contribution of nestin- and GLAST-lineage cells to adult hippocampal neurogenesis.","date":"2013","source":"Hippocampus","url":"https://pubmed.ncbi.nlm.nih.gov/23554226","citation_count":96,"is_preprint":false},{"pmid":"19139306","id":"PMC_19139306","title":"Episodic ataxia associated with EAAT1 mutation C186S affecting glutamate reuptake.","date":"2009","source":"Archives of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/19139306","citation_count":95,"is_preprint":false},{"pmid":"20489729","id":"PMC_20489729","title":"ASK1 deficiency attenuates neural cell death in GLAST-deficient mice, a model of normal tension glaucoma.","date":"2010","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/20489729","citation_count":85,"is_preprint":false},{"pmid":"11283952","id":"PMC_11283952","title":"Differential distribution of the glutamate transporters GLT-1 and GLAST in tanycytes of the third ventricle.","date":"2001","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/11283952","citation_count":82,"is_preprint":false},{"pmid":"10813794","id":"PMC_10813794","title":"Distribution of the glutamate transporters GLAST and GLT-1 in rat circumventricular organs, meninges, and dorsal root ganglia.","date":"2000","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/10813794","citation_count":81,"is_preprint":false},{"pmid":"10812203","id":"PMC_10812203","title":"Fine tuning of glutamate uptake and degradation in glial cells: common transcriptional regulation of GLAST1 and GS.","date":"2000","source":"Neurochemistry international","url":"https://pubmed.ncbi.nlm.nih.gov/10812203","citation_count":72,"is_preprint":false},{"pmid":"14749132","id":"PMC_14749132","title":"Glutamate transporters in platelets: EAAT1 decrease in aging and in Alzheimer's disease.","date":"2004","source":"Neurobiology of aging","url":"https://pubmed.ncbi.nlm.nih.gov/14749132","citation_count":71,"is_preprint":false},{"pmid":"11730698","id":"PMC_11730698","title":"Na+ dependent glutamate transporters (EAAT1, EAAT2, and EAAT3) in primary astrocyte cultures: effect of oxidative stress.","date":"2001","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/11730698","citation_count":69,"is_preprint":false},{"pmid":"20980602","id":"PMC_20980602","title":"Drosophila glial glutamate transporter Eaat1 is regulated by fringe-mediated notch signaling and is essential for larval locomotion.","date":"2010","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/20980602","citation_count":62,"is_preprint":false},{"pmid":"31523835","id":"PMC_31523835","title":"SLC1A3 contributes to L-asparaginase resistance in solid tumors.","date":"2019","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/31523835","citation_count":61,"is_preprint":false},{"pmid":"26269591","id":"PMC_26269591","title":"Transcriptional Regulation of the Astrocytic Excitatory Amino Acid Transporter 1 (EAAT1) via NF-κB and Yin Yang 1 (YY1).","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26269591","citation_count":61,"is_preprint":false},{"pmid":"25064059","id":"PMC_25064059","title":"Localization of excitatory amino acid transporters EAAT1 and EAAT2 in human postmortem cortex: a light and electron microscopic study.","date":"2014","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/25064059","citation_count":61,"is_preprint":false},{"pmid":"19156441","id":"PMC_19156441","title":"Effects of hyperglycemia and oxidative stress on the glutamate transporters GLAST and system xc- in mouse retinal Müller glial cells.","date":"2009","source":"Cell and tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/19156441","citation_count":61,"is_preprint":false},{"pmid":"33145952","id":"PMC_33145952","title":"SLC1A3 promotes gastric cancer progression via the PI3K/AKT signalling pathway.","date":"2020","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33145952","citation_count":58,"is_preprint":false},{"pmid":"14713304","id":"PMC_14713304","title":"Transcriptional regulation of human excitatory amino acid transporter 1 (EAAT1): cloning of the EAAT1 promoter and characterization of its basal and inducible activity in human astrocytes.","date":"2003","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14713304","citation_count":57,"is_preprint":false},{"pmid":"17346885","id":"PMC_17346885","title":"Amitriptyline preserves morphine's antinociceptive effect by regulating the glutamate transporter GLAST and GLT-1 trafficking and excitatory amino acids concentration in morphine-tolerant rats.","date":"2007","source":"Pain","url":"https://pubmed.ncbi.nlm.nih.gov/17346885","citation_count":57,"is_preprint":false},{"pmid":"21711518","id":"PMC_21711518","title":"Risk and protective genetic variants in suicidal behaviour: association with SLC1A2, SLC1A3, 5-HTR1B &NTRK2 polymorphisms.","date":"2011","source":"Behavioral and brain functions : BBF","url":"https://pubmed.ncbi.nlm.nih.gov/21711518","citation_count":56,"is_preprint":false},{"pmid":"18064044","id":"PMC_18064044","title":"The upregulation of GLAST-1 is an indirect antiapoptotic mechanism of GDNF and neurturin in the adult CNS.","date":"2007","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/18064044","citation_count":56,"is_preprint":false},{"pmid":"19338517","id":"PMC_19338517","title":"Excitatory amino acid transporters EAAT-1 and EAAT-2 in temporal lobe and hippocampus in intractable temporal lobe epilepsy.","date":"2009","source":"APMIS : acta pathologica, microbiologica, et immunologica Scandinavica","url":"https://pubmed.ncbi.nlm.nih.gov/19338517","citation_count":56,"is_preprint":false},{"pmid":"17330806","id":"PMC_17330806","title":"Expression of EAAT1 reflects a possible neuroprotective function of reactive astrocytes and activated microglia following human traumatic brain injury.","date":"2007","source":"Histology and histopathology","url":"https://pubmed.ncbi.nlm.nih.gov/17330806","citation_count":54,"is_preprint":false},{"pmid":"17543080","id":"PMC_17543080","title":"Reactive astrocytes and activated microglial cells express EAAT1, but not EAAT2, reflecting a neuroprotective potential following ischaemia.","date":"2007","source":"Histopathology","url":"https://pubmed.ncbi.nlm.nih.gov/17543080","citation_count":53,"is_preprint":false},{"pmid":"23939750","id":"PMC_23939750","title":"Laminar and subcellular heterogeneity of GLAST and GLT-1 immunoreactivity in the developing postnatal mouse hippocampus.","date":"2014","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/23939750","citation_count":51,"is_preprint":false},{"pmid":"19014361","id":"PMC_19014361","title":"Expression and distribution of 'high affinity' glutamate transporters GLT1, GLAST, EAAC1 and of GCPII in the rat peripheral nervous system.","date":"2008","source":"Journal of anatomy","url":"https://pubmed.ncbi.nlm.nih.gov/19014361","citation_count":51,"is_preprint":false},{"pmid":"9145792","id":"PMC_9145792","title":"Expression of glial glutamate transporters GLT-1 and GLAST is unchanged in the hippocampus in fully kindled rats.","date":"1997","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/9145792","citation_count":50,"is_preprint":false},{"pmid":"9630235","id":"PMC_9630235","title":"Expression of two glutamate transporters, GLAST and EAAT4, in the human cerebellum: their correlation in development and neonatal hypoxic-ischemic damage.","date":"1998","source":"Journal of neuropathology and experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/9630235","citation_count":49,"is_preprint":false},{"pmid":"17394550","id":"PMC_17394550","title":"Glutamate-dependent transcriptional regulation of GLAST/EAAT1: a role for YY1.","date":"2007","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17394550","citation_count":47,"is_preprint":false},{"pmid":"21233784","id":"PMC_21233784","title":"Genetic and functional studies of a missense variant in a glutamate transporter, SLC1A3, in Tourette syndrome.","date":"2011","source":"Psychiatric genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21233784","citation_count":47,"is_preprint":false},{"pmid":"16647773","id":"PMC_16647773","title":"Glutamate transporters GLAST and EAAT4 regulate postischemic Purkinje cell death: an in vivo study using a cardiac arrest model in mice lacking GLAST or EAAT4.","date":"2006","source":"Neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/16647773","citation_count":47,"is_preprint":false},{"pmid":"25972039","id":"PMC_25972039","title":"GLAST But Not Least--Distribution, Function, Genetics and Epigenetics of L-Glutamate Transport in Brain--Focus on GLAST/EAAT1.","date":"2015","source":"Neurochemical research","url":"https://pubmed.ncbi.nlm.nih.gov/25972039","citation_count":46,"is_preprint":false},{"pmid":"29778792","id":"PMC_29778792","title":"Valproic acid attenuates manganese-induced reduction in expression of GLT-1 and GLAST with concomitant changes in murine dopaminergic neurotoxicity.","date":"2018","source":"Neurotoxicology","url":"https://pubmed.ncbi.nlm.nih.gov/29778792","citation_count":45,"is_preprint":false},{"pmid":"17316900","id":"PMC_17316900","title":"Glutamate transporter GLAST/EAAT1 directs cell surface expression of FXYD2/gamma subunit of Na, K-ATPase in human fetal astrocytes.","date":"2007","source":"Neurochemistry international","url":"https://pubmed.ncbi.nlm.nih.gov/17316900","citation_count":44,"is_preprint":false},{"pmid":"21448920","id":"PMC_21448920","title":"BDNF regulates GLAST and glutamine synthetase in mouse retinal Müller cells.","date":"2012","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/21448920","citation_count":43,"is_preprint":false},{"pmid":"15569258","id":"PMC_15569258","title":"Differential regulation of GLAST immunoreactivity and activity by protein kinase C: evidence for modification of amino and carboxyl termini.","date":"2004","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15569258","citation_count":43,"is_preprint":false},{"pmid":"10719077","id":"PMC_10719077","title":"Modulation of glutamate transporters (GLAST, GLT-1 and EAAC1) in the rat cerebellum following portocaval anastomosis.","date":"2000","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/10719077","citation_count":42,"is_preprint":false},{"pmid":"17221839","id":"PMC_17221839","title":"Association study of polymorphisms in the glutamate transporter genes SLC1A1, SLC1A3, and SLC1A6 with schizophrenia.","date":"2007","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17221839","citation_count":42,"is_preprint":false},{"pmid":"12824049","id":"PMC_12824049","title":"Glutamate down-regulates GLAST expression through AMPA receptors in Bergmann glial cells.","date":"2003","source":"Brain research. Molecular brain research","url":"https://pubmed.ncbi.nlm.nih.gov/12824049","citation_count":42,"is_preprint":false},{"pmid":"18572325","id":"PMC_18572325","title":"Expression of glutamate transporters GLT-1 and GLAST in different regions of rat brain during the course of experimental autoimmune encephalomyelitis.","date":"2008","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/18572325","citation_count":41,"is_preprint":false},{"pmid":"8661010","id":"PMC_8661010","title":"Genomic organization, promoter analysis, and chromosomal localization of the gene for the mouse glial high-affinity glutamate transporter Slc1a3.","date":"1996","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/8661010","citation_count":40,"is_preprint":false},{"pmid":"27476799","id":"PMC_27476799","title":"Novel Genetic Variants Associated With Increased Vertebral Volumetric BMD, Reduced Vertebral Fracture Risk, and Increased Expression of SLC1A3 and EPHB2.","date":"2016","source":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research","url":"https://pubmed.ncbi.nlm.nih.gov/27476799","citation_count":38,"is_preprint":false},{"pmid":"28812276","id":"PMC_28812276","title":"Arundic Acid Increases Expression and Function of Astrocytic Glutamate Transporter EAAT1 Via the ERK, Akt, and NF-κB Pathways.","date":"2017","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/28812276","citation_count":38,"is_preprint":false},{"pmid":"11784698","id":"PMC_11784698","title":"The expression of the glutamate re-uptake transporter excitatory amino acid transporter 1 (EAAT1) in the normal human CNS and in motor neurone disease: an immunohistochemical study.","date":"2002","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/11784698","citation_count":38,"is_preprint":false},{"pmid":"31582286","id":"PMC_31582286","title":"In vivo knockdown of astroglial glutamate transporters GLT-1 and GLAST increases excitatory neurotransmission in mouse infralimbic cortex: Relevance for depressive-like phenotypes.","date":"2019","source":"European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/31582286","citation_count":38,"is_preprint":false},{"pmid":"20558201","id":"PMC_20558201","title":"The food-associated fungal neurotoxin ochratoxin A inhibits the absorption of glutamate by astrocytes through a decrease in cell surface expression of the excitatory amino-acid transporters GLAST and GLT-1.","date":"2010","source":"Neurotoxicology","url":"https://pubmed.ncbi.nlm.nih.gov/20558201","citation_count":38,"is_preprint":false},{"pmid":"27829685","id":"PMC_27829685","title":"Late-onset episodic ataxia associated with SLC1A3 mutation.","date":"2016","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27829685","citation_count":36,"is_preprint":false},{"pmid":"37005761","id":"PMC_37005761","title":"Glial Glutamate Transporter-Mediated Plasticity: System xc-/xCT/SLC7A11 and EAAT1/2 in Brain Diseases.","date":"2023","source":"Frontiers in bioscience (Landmark edition)","url":"https://pubmed.ncbi.nlm.nih.gov/37005761","citation_count":36,"is_preprint":false},{"pmid":"29615452","id":"PMC_29615452","title":"Glutamate transporter Slc1a3 mediates inter-niche stem cell activation during skin growth.","date":"2018","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/29615452","citation_count":36,"is_preprint":false},{"pmid":"18336953","id":"PMC_18336953","title":"Valproate-dependent transcriptional regulation of GLAST/EAAT1 expression: involvement of Ying-Yang 1.","date":"2008","source":"Neurochemistry international","url":"https://pubmed.ncbi.nlm.nih.gov/18336953","citation_count":36,"is_preprint":false},{"pmid":"24300109","id":"PMC_24300109","title":"Primary cultures of rat cortical microglia treated with nicotine increases in the expression of excitatory amino acid transporter 1 (GLAST) via the activation of the α7 nicotinic acetylcholine receptor.","date":"2013","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/24300109","citation_count":34,"is_preprint":false},{"pmid":"29066757","id":"PMC_29066757","title":"Impaired K+ binding to glial glutamate transporter EAAT1 in migraine.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/29066757","citation_count":33,"is_preprint":false},{"pmid":"29741614","id":"PMC_29741614","title":"Loss of cerebellar glutamate transporters EAAT4 and GLAST differentially affects the spontaneous firing pattern and survival of Purkinje cells.","date":"2018","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/29741614","citation_count":33,"is_preprint":false},{"pmid":"10915646","id":"PMC_10915646","title":"EAAT1 is involved in transport of L-glutamate during differentiation of the Caco-2 cell line.","date":"2000","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/10915646","citation_count":32,"is_preprint":false},{"pmid":"30418668","id":"PMC_30418668","title":"Altered function of the glutamate-aspartate transporter GLAST, a potential therapeutic target in glioblastoma.","date":"2019","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/30418668","citation_count":31,"is_preprint":false},{"pmid":"32741053","id":"PMC_32741053","title":"Functional consequences of SLC1A3 mutations associated with episodic ataxia 6.","date":"2020","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/32741053","citation_count":30,"is_preprint":false},{"pmid":"31158434","id":"PMC_31158434","title":"Regulation of Synaptosomal GLT-1 and GLAST during Epileptogenesis.","date":"2019","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/31158434","citation_count":30,"is_preprint":false},{"pmid":"15535133","id":"PMC_15535133","title":"Expression of excitatory amino acid transporter-1 (EAAT-1) in brain macrophages and microglia of patients with prion diseases.","date":"2004","source":"Journal of neuropathology and experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/15535133","citation_count":29,"is_preprint":false},{"pmid":"29208948","id":"PMC_29208948","title":"A novel mutation in SLC1A3 causes episodic ataxia.","date":"2017","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/29208948","citation_count":28,"is_preprint":false},{"pmid":"21856347","id":"PMC_21856347","title":"Signaling through EAAT-1/GLAST in cultured Bergmann glia cells.","date":"2011","source":"Neurochemistry international","url":"https://pubmed.ncbi.nlm.nih.gov/21856347","citation_count":27,"is_preprint":false},{"pmid":"16286679","id":"PMC_16286679","title":"Methylmercury alters the in vitro uptake of glutamate in GLAST- and GLT-1-transfected mutant CHO-K1 cells.","date":"2005","source":"Biological trace element research","url":"https://pubmed.ncbi.nlm.nih.gov/16286679","citation_count":27,"is_preprint":false},{"pmid":"18371048","id":"PMC_18371048","title":"Inhibitory regulation of glutamate aspartate transporter (GLAST) expression in astrocytes by cadmium-induced calcium influx.","date":"2008","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18371048","citation_count":27,"is_preprint":false},{"pmid":"21602192","id":"PMC_21602192","title":"Arsenite exposure downregulates EAAT1/GLAST transporter expression in glial cells.","date":"2011","source":"Toxicological sciences : an official journal of the Society of Toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/21602192","citation_count":26,"is_preprint":false},{"pmid":"29737454","id":"PMC_29737454","title":"Targeting β-Catenin in GLAST-Expressing Cells: Impact on Anxiety and Depression-Related Behavior and Hippocampal Proliferation.","date":"2018","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/29737454","citation_count":26,"is_preprint":false},{"pmid":"20070863","id":"PMC_20070863","title":"Ca(2+)-dependent reduction of glutamate aspartate transporter GLAST expression in astrocytes by P2X(7) receptor-mediated phosphoinositide 3-kinase signaling.","date":"2010","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20070863","citation_count":26,"is_preprint":false},{"pmid":"35993169","id":"PMC_35993169","title":"SLC1A3 facilitates Newcastle disease virus replication by regulating glutamine catabolism.","date":"2022","source":"Virulence","url":"https://pubmed.ncbi.nlm.nih.gov/35993169","citation_count":25,"is_preprint":false},{"pmid":"15950021","id":"PMC_15950021","title":"A family based study implicates solute carrier family 1-member 3 (SLC1A3) gene in attention-deficit/hyperactivity disorder.","date":"2005","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/15950021","citation_count":25,"is_preprint":false},{"pmid":"17627080","id":"PMC_17627080","title":"Regulation of the mGluR5, EAAT1 and GS expression by glucocorticoids in MG-63 osteoblast-like osteosarcoma cells.","date":"2007","source":"Journal of musculoskeletal & neuronal interactions","url":"https://pubmed.ncbi.nlm.nih.gov/17627080","citation_count":24,"is_preprint":false},{"pmid":"8647279","id":"PMC_8647279","title":"Human high affinity, Na(+)-dependent L-glutamate/L-aspartate transporter GLAST-1 (EAAT-1): gene structure and localization to chromosome 5p11-p12.","date":"1996","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/8647279","citation_count":24,"is_preprint":false},{"pmid":"26391563","id":"PMC_26391563","title":"Thrombin decreases expression of the glutamate transporter GLAST and inhibits glutamate uptake in primary cortical astrocytes via the Rho kinase pathway.","date":"2015","source":"Experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/26391563","citation_count":24,"is_preprint":false},{"pmid":"30771902","id":"PMC_30771902","title":"CD133 promotes the self-renewal capacity of thyroid cancer stem cells through activation of glutamate aspartate transporter SLC1A3 expression.","date":"2019","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/30771902","citation_count":23,"is_preprint":false},{"pmid":"25152321","id":"PMC_25152321","title":"Pharmacological inhibitions of glutamate transporters EAAT1 and EAAT2 compromise glutamate transport in photoreceptor to ON-bipolar cell synapses.","date":"2014","source":"Vision research","url":"https://pubmed.ncbi.nlm.nih.gov/25152321","citation_count":22,"is_preprint":false},{"pmid":"12440940","id":"PMC_12440940","title":"The glutamate transporter GLAST-1 (EAAT-1) is expressed in the plasma membrane of osteocytes and is responsive to extracellular glutamate concentration.","date":"2002","source":"Biochemical Society transactions","url":"https://pubmed.ncbi.nlm.nih.gov/12440940","citation_count":22,"is_preprint":false},{"pmid":"27296938","id":"PMC_27296938","title":"Duplications of SLC1A3: Associated with ADHD and autism.","date":"2016","source":"European journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27296938","citation_count":22,"is_preprint":false},{"pmid":"17289278","id":"PMC_17289278","title":"Subcellular localization of the glutamate transporters GLAST and GLT at the neuromuscular junction in rodents.","date":"2007","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/17289278","citation_count":22,"is_preprint":false},{"pmid":"27889915","id":"PMC_27889915","title":"Constitutive regulation of the glutamate/aspartate transporter EAAT1 by Calcium-Calmodulin-Dependent Protein Kinase II.","date":"2017","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/27889915","citation_count":21,"is_preprint":false},{"pmid":"16516348","id":"PMC_16516348","title":"High-affinity glutamate transporter GLAST/EAAT1 regulates cell surface expression of glutamine/neutral amino acid transporter ASCT2 in human fetal astrocytes.","date":"2006","source":"Neurochemistry international","url":"https://pubmed.ncbi.nlm.nih.gov/16516348","citation_count":21,"is_preprint":false},{"pmid":"19551376","id":"PMC_19551376","title":"Differential expression of two glutamate transporters, GLAST and GLT-1, in an experimental rat model of glaucoma.","date":"2009","source":"Experimental brain research","url":"https://pubmed.ncbi.nlm.nih.gov/19551376","citation_count":21,"is_preprint":false},{"pmid":"22252783","id":"PMC_22252783","title":"Transcriptional regulation of the GLAST/EAAT-1 gene in rat and man.","date":"2012","source":"Cellular and molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/22252783","citation_count":20,"is_preprint":false},{"pmid":"16034155","id":"PMC_16034155","title":"In vitro uptake of glutamate in GLAST- and GLT-1-transfected mutant CHO-K1 cells is inhibited by the ethylmercury-containing preservative thimerosal.","date":"2005","source":"Biological trace element research","url":"https://pubmed.ncbi.nlm.nih.gov/16034155","citation_count":20,"is_preprint":false},{"pmid":"15547463","id":"PMC_15547463","title":"Ethanol induces expression of the glutamate transporters EAAT1 and EAAT2 in organotypic cortical slice cultures.","date":"2004","source":"Alcoholism, clinical and experimental research","url":"https://pubmed.ncbi.nlm.nih.gov/15547463","citation_count":19,"is_preprint":false},{"pmid":"12225864","id":"PMC_12225864","title":"Expression of glutamate transporters and ionotropic glutamate receptors in GLAST knockout mice.","date":"2002","source":"Brain research. Molecular brain research","url":"https://pubmed.ncbi.nlm.nih.gov/12225864","citation_count":19,"is_preprint":false},{"pmid":"25454285","id":"PMC_25454285","title":"Differential regulation of the glutamate transporters GLT-1 and GLAST by GSK3β.","date":"2014","source":"Neurochemistry international","url":"https://pubmed.ncbi.nlm.nih.gov/25454285","citation_count":19,"is_preprint":false},{"pmid":"33753288","id":"PMC_33753288","title":"Chronic optogenetic stimulation of Bergman glia leads to dysfunction of EAAT1 and Purkinje cell death, mimicking the events caused by expression of pathogenic ataxin-1.","date":"2021","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/33753288","citation_count":19,"is_preprint":false},{"pmid":"17379211","id":"PMC_17379211","title":"EAAT1 and D-serine expression are early features of human retinal development.","date":"2007","source":"Experimental eye research","url":"https://pubmed.ncbi.nlm.nih.gov/17379211","citation_count":18,"is_preprint":false},{"pmid":"10087511","id":"PMC_10087511","title":"The L-glutamate transporters GLAST (EAAT1) and GLT-1 (EAAT2): expression and regulation in rat lactating mammary gland.","date":"1998","source":"Molecular membrane biology","url":"https://pubmed.ncbi.nlm.nih.gov/10087511","citation_count":18,"is_preprint":false},{"pmid":"8001975","id":"PMC_8001975","title":"The mouse and human excitatory amino acid transporter gene (EAAT1) maps to mouse chromosome 15 and a region of syntenic homology on human chromosome 5.","date":"1994","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/8001975","citation_count":18,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":54199,"output_tokens":8878,"usd":0.147884,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":19012,"output_tokens":6142,"usd":0.124305,"stage2_stop_reason":"end_turn"},"total_usd":0.272189,"stage1_batch_id":"msgbatch_013LWZZT6MWaqB9qyTSeQBmU","stage2_batch_id":"msgbatch_0194ZzQaTGNpruoNJBbEMbt3","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2005,\n      \"finding\": \"A heterozygous missense mutation in SLC1A3/EAAT1 causes markedly reduced glutamate uptake capacity. When co-expressed, the mutant EAAT1 specifically decreased wild-type EAAT1 activity (dominant-negative effect) but did not affect EAAT2 or EAAT3, indicating that mutant EAAT1 multimerizes specifically with wild-type EAAT1.\",\n      \"method\": \"Heterologous expression of mutant EAAT1, glutamate uptake assays, co-expression dominant-negative experiments\",\n      \"journal\": \"Neurology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — in vitro uptake assay plus functional co-expression dominant-negative analysis, single lab but multiple orthogonal functional methods\",\n      \"pmids\": [\"16116111\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Surface expression and transport activity of EAAT1 are regulated by the ubiquitin ligase Nedd4-2 and serum/glucocorticoid-inducible kinases SGK1/SGK3 and protein kinase B (PKB). Nedd4-2 co-expression decreases EAAT1-mediated glutamate currents in Xenopus oocytes, an effect reversed by constitutively active SGK1, SGK3, or PKB. Site-directed mutagenesis identified phosphorylation site T482 in EAAT1 as important, with a phospho-mimetic T482D mutation increasing transport activity.\",\n      \"method\": \"Xenopus oocyte expression, electrophysiological recording of glutamate-induced currents, site-directed mutagenesis of EAAT1 and Nedd4-2\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution in oocytes with mutagenesis at multiple sites, single lab but multiple orthogonal methods (electrophysiology + mutagenesis)\",\n      \"pmids\": [\"12911626\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Glutamate stimulates its own uptake in astrocytes by rapidly increasing GLAST/EAAT1 expression at the cell surface (increased Vmax). This effect requires transporter activity (not receptor activation), is mimicked by the non-metabolizable substrate D-aspartate, does not occur in Na+-free medium, and is blocked by actin-disrupting agents cytochalasin B and D, indicating actin cytoskeleton-dependent trafficking of GLAST to the plasma membrane.\",\n      \"method\": \"Primary astrocyte cultures, glutamate uptake assays, biotinylation labeling of cell-surface proteins, pharmacological inhibition of actin polymerization\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell-surface biotinylation with functional uptake assay and pharmacological dissection, single lab, multiple orthogonal approaches\",\n      \"pmids\": [\"10575016\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Protein kinase C (PKC) activation by PMA acutely increases GLAST transport activity (~20%) in primary astrocytes but simultaneously reduces total and cell-surface GLAST immunoreactivity, indicating PKC modifies multiple intracellular epitopes of GLAST. Flag-tagged GLAST introduced by lentiviral vectors showed no change in flag immunoreactivity despite loss of GLAST antibody signal, demonstrating PKC causes post-translational modification of cytoplasmic epitopes rather than protein loss.\",\n      \"method\": \"Primary astrocyte cultures, phorbol ester treatment, glutamate transport assays, biotinylation of cell-surface proteins, lentiviral transduction of flag-tagged GLAST, PKC inhibitor bisindolylmaleimide II\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (functional transport + immunoreactivity + flag-epitope-tagged construct), single lab\",\n      \"pmids\": [\"15569258\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"CaMKII constitutively regulates EAAT1 glutamate transport activity. Pharmacological inhibition of CaMKII reduces EAAT1-mediated [3H]-glutamate uptake in HEK293T cells. SPOTS peptide array and GST-fusion protein binding identified phosphorylation sites T26 and T37 in EAAT1's N-terminus as CaMKII substrates; a non-phosphorylatable T37A mutation diminished EAAT1-mediated glutamate uptake, identifying CaMKII-mediated phosphorylation at T37 as important for constitutive EAAT1 function.\",\n      \"method\": \"HEK293T heterologous expression, [3H]-glutamate uptake assay, SPOTS peptide array, GST-fusion protein biochemistry, site-directed mutagenesis (T37A), dominant-negative CaMKII overexpression\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with mutagenesis and direct substrate identification by peptide array, single lab but multiple orthogonal methods\",\n      \"pmids\": [\"27889915\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"A C186S missense mutation in EAAT1/SLC1A3 causes a modest but significant reduction in glutamate uptake. This mutation segregates with episodic ataxia in a family, and the severity of EA6 symptoms correlates with the degree of glutamate transporter dysfunction.\",\n      \"method\": \"Direct sequencing of SLC1A3, glutamate uptake assay in cells expressing mutant EAAT1\",\n      \"journal\": \"Archives of neurology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — functional uptake assay in heterologous expression, single lab, single method for functional analysis\",\n      \"pmids\": [\"19139306\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"A T387P mutation in hEAAT1 identified in a migraine patient diminishes glutamate uptake rates and reduces EAAT1 surface membrane expression. Whole-cell patch clamp and fast substrate application showed that T387P specifically abolishes K+-bound retranslocation while preserving Na+-dependent anion currents, identifying impaired K+ binding as a novel mechanism of glutamate transport dysfunction.\",\n      \"method\": \"Heterologous expression in mammalian cells, whole-cell patch clamp, fast substrate application, Western blot/biochemical analysis of surface expression\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — electrophysiology with fast substrate application and biochemistry in a single rigorous study defining the mechanistic step (K+-retranslocation)\",\n      \"pmids\": [\"29066757\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Functional consequences of all known EA6-associated SLC1A3 mutations were compared: mutations cause a range of impairments including reduced transport function, impaired trafficking to the plasma membrane, and increased protein expression. Many mutations caused only slight individual changes, demonstrating that the cerebellum is highly sensitive to even partial EAAT1 dysfunction.\",\n      \"method\": \"Heterologous expression in mammalian cells, confocal imaging, Western blot, whole-cell patch clamp recording of transport and anion currents\",\n      \"journal\": \"Human mutation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — systematic multiparameter functional characterization (electrophysiology + imaging + biochemistry) across multiple mutations in a single study\",\n      \"pmids\": [\"32741053\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"A missense variant E219D in SLC1A3 increases glutamate uptake 1.66-fold and increases surface membrane EAAT1 protein 1.5-fold in HEK293 cells, demonstrating a gain-of-function effect on transport activity.\",\n      \"method\": \"[3H]-glutamate uptake assay and biotin-mediated membrane protein pull-down in transfected HEK293 cells\",\n      \"journal\": \"Psychiatric genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — two complementary methods (functional assay + surface biochemistry), single lab\",\n      \"pmids\": [\"21233784\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"GLAST/EAAT1 activity directs FXYD2/gamma subunit of Na+,K+-ATPase to the astrocyte cell surface. When GLAST transport was blocked by TFB-TBOA, FXYD2 surface expression was reduced; siRNA knockdown of FXYD2 did not affect GLAST trafficking but abolished the glutamate uptake-dependent activation of Na+,K+-ATPase, demonstrating that GLAST activity drives FXYD2 trafficking which in turn modulates the sodium pump.\",\n      \"method\": \"Primary human fetal astrocyte cultures, glutamate uptake assays, biotinylation of surface proteins, siRNA knockdown of FXYD2, selective transporter inhibitor TFB-TBOA\",\n      \"journal\": \"Neurochemistry international\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple methods (biochemistry + siRNA knockdown + functional assays), single lab\",\n      \"pmids\": [\"17316900\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"GLAST/EAAT1 expression in astrocytes is required to sustain normal spontaneous simple spike activity in zebrin-negative Purkinje cells by restricting NMDA receptor activation. In GLAST knockout mice, NMDA receptor blockade restored spontaneous PC activity and alleviated motor deficits, placing GLAST upstream of NMDA receptor overactivation in the cerebellum.\",\n      \"method\": \"GLAST knockout mice, in vivo electrophysiology (spontaneous Purkinje cell firing), pharmacological NMDA receptor blockade, behavioral motor testing\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout with electrophysiological phenotype rescue by pharmacological epistasis, replicated across multiple experimental approaches\",\n      \"pmids\": [\"29741614\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"GLAST knockout mice show selective loss of Purkinje cells with low EAAT4 expression after global brain ischemia, demonstrating that GLAST protects against excitotoxic cerebellar damage in concert with EAAT4.\",\n      \"method\": \"GLAST and EAAT4 knockout mice, cardiac arrest model, histological quantification of Purkinje cell loss\",\n      \"journal\": \"Neuroscience research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis using two knockout models in vivo, single lab\",\n      \"pmids\": [\"16647773\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"In GLAST-deficient mice (a model of normal tension glaucoma), ASK1 deficiency protects retinal ganglion cells and improves visual function. TNF-induced activation of p38 MAPK and iNOS production were suppressed in ASK1-deficient Müller glia, and TNF-induced RGC death was suppressed in ASK1-deficient RGCs, placing ASK1 downstream of GLAST-loss-induced oxidative/TNF stress leading to RGC apoptosis.\",\n      \"method\": \"GLAST-/- and ASK1-/- double knockout mice, multifocal electroretinography, histology, biochemical analysis of glutathione and malondialdehyde, cell death assays in primary Müller cells and RGCs\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis with multiple outcome measures (visual function, histology, biochemistry), single lab\",\n      \"pmids\": [\"20489729\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Long-term treatment of astrocytes with L-glutamate or kainate (but not AMPA or tACPD) causes up-regulation of GLAST protein and increased D-aspartate uptake. The effect of glutamate is blocked by the kainate/AMPA receptor antagonist CNQX, and is mimicked by dbcAMP, indicating GLAST expression is regulated post-transcriptionally through kainate-type glutamate receptor signaling.\",\n      \"method\": \"Primary astrocyte cultures, D-[3H]aspartate uptake assays, Western blot quantification of GLAST protein, pharmacological receptor antagonists\",\n      \"journal\": \"Neuroreport\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional uptake assay combined with Western blot and pharmacological dissection, replicated with multiple agonists/antagonists, single lab\",\n      \"pmids\": [\"9051792\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Glutamate down-regulates GLAST mRNA levels and promoter activity in Bergmann glia via Ca2+-permeable AMPA receptors, with involvement of protein kinase C and the transcription factor c-Jun.\",\n      \"method\": \"Primary chick cerebellar Bergmann glia cultures, [3H]-D-aspartate uptake, promoter-reporter assays, RT-PCR, pharmacological inhibitors of AMPA receptors/PKC\",\n      \"journal\": \"Brain research. Molecular brain research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reporter assay plus mRNA analysis plus pharmacological dissection, single lab, multiple methods\",\n      \"pmids\": [\"12824049\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"YY1 (Ying-Yang 1) transcription factor mediates glutamate-induced transcriptional repression of GLAST/EAAT1. Glutamate increases YY1 DNA binding; overexpression of YY1 reduces GLAST uptake, mRNA levels, and chglast promoter activity; a YY1 binding site in the GLAST promoter is required for the glutamate-dependent repression.\",\n      \"method\": \"Cultured chick cerebellar Bergmann glia, promoter-reporter assay with YY1 site mutations, [3H]-D-aspartate uptake, RT-PCR, EMSA for YY1 binding\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — promoter reporter assay with mutation analysis plus functional uptake assay plus EMSA, single lab\",\n      \"pmids\": [\"17394550\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"NF-κB is a positive transcriptional regulator of EAAT1/GLAST; mutation of NF-κB binding sites in the EAAT1 promoter decreases activity, and NF-κB inhibition reduces EAAT1 mRNA/protein levels and glutamate uptake. YY1 acts as a critical negative regulator, with HDAC co-repressors; manganese decreases EAAT1 expression via YY1, and HDAC inhibition reverses this. EGF increases EAAT1 expression via NF-κB.\",\n      \"method\": \"Human astrocyte H4 cells, promoter-reporter assays with NF-κB and YY1 site mutations, siRNA knockdown of YY1, NF-κB inhibition, RT-qPCR, Western blot, glutamate uptake assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — promoter mutagenesis, siRNA knockdown, pharmacological inhibition, and functional uptake assay in a single study with multiple orthogonal methods\",\n      \"pmids\": [\"26269591\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"The human EAAT1 promoter core element (−57 to +20 bp) is TATA-box-less and depends on a GC-box at −52/−39 bound by Sp1/Sp3 and an E-box near the TSS bound by USF1. cAMP and EGF increase EAAT1 promoter activity and mRNA/glutamate uptake in human astrocytes; TNF-α reduces both promoter activity and EAAT1 mRNA expression.\",\n      \"method\": \"Cloning and transfection of human EAAT1 promoter deletion constructs, EMSA, supershift and competition assays, RT-PCR, glutamate uptake assay in primary human astrocytes\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — promoter deletion/mutation analysis with EMSA identification of binding proteins plus functional assays, single lab\",\n      \"pmids\": [\"14713304\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"GLAST/EAAT1 transport activity triggers mTOR phosphorylation (Ser2448) and downstream signaling in Bergmann glia. D-aspartate and other transported substrates (but not non-transported ligands) activate a cascade involving Ca2+ influx, PI3K, and PKB, leading to increased AP-1 DNA binding and upregulation of AP-1-driven transcription.\",\n      \"method\": \"Primary chick cerebellar Bergmann glia, D-aspartate and transporter ligand treatments, mTOR phosphorylation assays, pharmacological inhibitors, AP-1 reporter gene assays\",\n      \"journal\": \"Neurochemistry international\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological dissection with reporter assay and phosphorylation analysis, single lab, multiple methods but all in one system\",\n      \"pmids\": [\"21856347\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"GDNF upregulates GLAST-1 expression via phosphoinositide-3 kinase (PI3K) and Src kinase activity; neurturin upregulates GLAST-1 via PI3K alone. RNA interference demonstrating that GLAST-1 upregulation by GDNF and neurturin is required for their neuroprotective rescue of retinal ganglion cells after optic nerve transection, establishing GLAST-1 upregulation as an indirect neuroprotective mechanism.\",\n      \"method\": \"Adult rat retina, GDNF/NTN intravitreal application, PI3K and Src kinase inhibitors, siRNA knockdown of GLAST-1, RGC survival counting after optic nerve transection\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pathway inhibitors plus RNAi with in vivo cell survival readout, single lab\",\n      \"pmids\": [\"18064044\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"P2X7 receptor activation by ATP decreases GLAST mRNA stability in astrocytes via a Ca2+-dependent PI3K–PLCγ–IP3R–CaMKII–PKC signaling cascade. This mechanism was demonstrated by P2X7R blockade, P2X7R siRNA knockdown, promoter deletion assays, and RNA decay assays.\",\n      \"method\": \"Primary rat cortical astrocytes, ATP and BzATP treatment, P2X7R antagonist (oxATP) and shRNA knockdown, GLAST promoter deletion assays, RNA decay assays, Ca2+ chelation, pharmacological pathway inhibitors\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (RNAi, pharmacology, promoter and RNA stability assays) dissecting a specific signaling pathway, single lab\",\n      \"pmids\": [\"20070863\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"GSK3β differentially regulates GLT-1 and GLAST: in heterologous expression systems (COS-7 cells and Xenopus oocytes), GSK3β stimulates GLT-1 activity and reduces GLAST activity, with corresponding changes in plasma membrane amounts. GSK3β increases phosphorylation of GLAST while decreasing that of GLT-1. Pharmacological GSK3β inhibition in primary rat cortical cultures also differentially modulates the two transporters.\",\n      \"method\": \"COS-7 cell and Xenopus oocyte heterologous expression, transporter activity assays, plasma membrane quantification, 32Pi incorporation (phosphorylation), GSK3β inhibitors and dominant-negative kinase, primary rat cortical astrocyte cultures\",\n      \"journal\": \"Neurochemistry international\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — two heterologous expression systems plus primary cultures with functional and biochemical endpoints, single lab\",\n      \"pmids\": [\"25454285\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"p53 promotes expression of SLC1A3, an aspartate/glutamate transporter, under glutamine deprivation. SLC1A3 expression maintains electron transport chain and TCA cycle activity and supports de novo glutamate, glutamine, and nucleotide synthesis to rescue cell viability. SLC1A3 depletion retards tumor growth in vitro and in vivo, establishing SLC1A3 as a mediator of p53-dependent metabolic adaptation.\",\n      \"method\": \"Cell viability assays, metabolic flux analysis (isotope tracing), xenograft tumor growth, SLC1A3 knockdown and overexpression, p53 reporter and ChIP-inferred transcriptional regulation\",\n      \"journal\": \"Cell metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (metabolic flux, in vivo xenograft, gain- and loss-of-function) in a single study replicated across cell lines and in vivo\",\n      \"pmids\": [\"30122553\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"SLC1A3 mediates aspartate/glutamate uptake that fuels ASNase resistance in solid tumor cells by supporting TCA cycle, urea cycle, nucleotide biosynthesis, energy production, redox homeostasis, and lipid biosynthesis. In vivo, SLC1A3 expression promoted tumor development and metastasis while negating ASNase suppressive effects.\",\n      \"method\": \"Functional genetic screen, siRNA/shRNA knockdown, cell cycle and apoptosis assays, metabolic profiling, xenograft tumor models in mice\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — functional genetic screen followed by mechanistic validation with multiple metabolic endpoints and in vivo models, single lab but highly replicated methodology\",\n      \"pmids\": [\"31523835\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"In Drosophila, Eaat1 (ortholog of mammalian GLAST/EAAT1) expression in CNS glia is regulated by the glycosyltransferase Fringe via Delta-Notch ligand-receptor signaling from neurons to glia during embryogenesis. Loss-of-function Eaat1 mutations cause failure of rhythmic peristaltic crawling in larvae, associated with altered synaptic current frequency, amplitude, and kinetics in motor neurons, establishing Eaat1 as essential for glutamate homeostasis in CNS circuits controlling locomotion.\",\n      \"method\": \"Drosophila genetics (loss-of-function mutations, Fringe/Notch pathway manipulation), electrophysiology of motor neuron synaptic currents, behavioral locomotion assays, postembryonic inactivation experiments\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic loss-of-function with electrophysiological and behavioral readouts plus pathway epistasis (Fringe-Notch-Eaat1), replicated across multiple experimental approaches\",\n      \"pmids\": [\"20980602\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"During hair growth, SLC1A3 is transiently upregulated in proliferating stem/progenitor cells in hair follicle bulge, sebaceous gland, and interfollicular epidermis. Deletion of slc1a3 delays hair follicle anagen entry and uncouples IFE and SG expansion from the hair cycle. Modulation of metabotropic glutamate receptor 5 (mGluR5) activity mimics the effects of SLC1A3 deletion or inhibition, suggesting SLC1A3 acts upstream of mGluR5 signaling to coordinate stem/progenitor cell activation across skin niches.\",\n      \"method\": \"Transgenic fate-mapping in mice, slc1a3 conditional knockout, BrdU/Ki67 proliferation assays, pharmacological mGluR5 modulation, hair cycle staging\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional knockout with fate mapping and pharmacological epistasis, multiple niche readouts, single lab but rigorous multi-method design\",\n      \"pmids\": [\"29615452\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Amitriptyline induces trafficking of GLAST and GLT-1 from cytosol onto the glial cell surface in morphine-tolerant rats by inhibiting phospho-PKA and PKC (PKCα, PKCβII, PKCγ) expression; the same PKA/PKC inhibitors alone also induced GLAST/GLT-1 trafficking. This trafficking correlates with suppression of morphine-evoked EAA (glutamate, aspartate) release in spinal CSF.\",\n      \"method\": \"Intrathecal morphine-tolerant rat model, antinociception dose-response curves, PKA/PKC inhibitor treatments, synaptosomal surface biotinylation, Western blot of GLAST/GLT-1 cytosol vs. membrane, microdialysis/amino acid measurement in CSF\",\n      \"journal\": \"Pain\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — surface biotinylation plus in vivo pharmacological pathway dissection with functional CSF amino acid readout, single lab\",\n      \"pmids\": [\"17346885\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"GLAST-1 protein localizes to the plasma membrane of osteocytes in a glutamate-concentration-dependent manner: low extracellular glutamate redistributes GLAST-1-GFP to intracellular vesicles, while a splice variant (GLAST-1a, lacking exon 3) constitutively localizes to internal vesicles and does not traffic to the plasma membrane.\",\n      \"method\": \"Transfection of GFP-tagged GLAST-1 and GLAST-1a into MLO-Y4 osteocytes, fluorescence microscopy, RT-PCR\",\n      \"journal\": \"Biochemical Society transactions\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single imaging method in a single report, limited functional validation\",\n      \"pmids\": [\"12440940\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"In glioblastoma (GBM) stem-like cells, GLAST is expressed but cells release rather than take up glutamate due to lack of Na+/K+-ATPase. Overexpression of Na+/K+-ATPase in GBM stem-like cells restores glutamate uptake and induces apoptosis, demonstrating that GLAST transport direction in tumor cells depends on Na+/K+-ATPase activity. Intratumoral injection of GLAST inhibitor UCPH-101 significantly increased survival of glioma-bearing mice.\",\n      \"method\": \"GBM stem cell cultures, Na+/K+-ATPase overexpression, glutamate release/uptake assays, apoptosis assays, MR spectroscopy, mouse xenograft with UCPH-101 treatment\",\n      \"journal\": \"International journal of cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain-of-function rescue experiment plus in vivo pharmacological inhibition, single lab, multiple methods\",\n      \"pmids\": [\"30418668\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"GLAST/EAAT1 regulates cell-surface expression of the neutral amino acid transporter ASCT2 in human fetal astrocytes: glutamate transported by GLAST is converted to glutamine by glutamine synthetase (GS), and this intracellular glutamine is a more potent inducer of ASCT2 trafficking to the cell surface than direct ASCT2 substrates. siRNA knockdown of GS abolished the glutamate-dependent ASCT2 trafficking effect.\",\n      \"method\": \"Primary human fetal astrocyte cultures, cAMP-induced differentiation, siRNA knockdown of GS, biotinylation of surface proteins, fluorescence microscopy, TFB-TBOA transporter block\",\n      \"journal\": \"Neurochemistry international\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA knockdown plus surface biotinylation and pharmacological transport block, single lab\",\n      \"pmids\": [\"16516348\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Chronic optogenetic activation of Bergmann glia reduces EAAT1 function, prolongs excitatory postsynaptic currents in Purkinje cells, and causes astroglyosis and Purkinje cell atrophy—phenotypes identical to those caused by expression of polyglutamine-expanded ataxin-1 in Bergmann glia, establishing that excessive glutamate signaling from EAAT1 dysfunction is a driver of SCA1-like cerebellar neurodegeneration.\",\n      \"method\": \"Mouse Bergmann glia-targeted optogenetics (ChR2), patch clamp recordings of EPSC kinetics in Purkinje cells, histological analysis of astroglyosis and Purkinje cell atrophy, comparison with ataxin-1[Q85] and ataxin-1[Q154] knock-in mouse models\",\n      \"journal\": \"Neurobiology of disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — three independent models (optogenetic, transgenic overexpression, knock-in) with electrophysiological readout, single lab\",\n      \"pmids\": [\"33753288\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"The mouse Slc1a3 gene spans >56 kb with 10 exons, maps to chromosome 15A2, and contains a CCAAT box and GC box (but no TATA box) in its promoter. A 4-kb 5'-flanking region drives luciferase expression in COS-1 cells; deletion to 619 bp causes a marked decrease, identifying the CCAAT box at −200 as necessary for expression.\",\n      \"method\": \"Genomic library screening, restriction mapping, primer extension, promoter-luciferase reporter assays in COS-1 cells, in situ hybridization chromosomal localization\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — promoter deletion reporter assays with chromosomal mapping, single lab, multiple methods\",\n      \"pmids\": [\"8661010\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"SLC1A3/EAAT1/GLAST is a Na+-K+-H+-coupled high-affinity glutamate/aspartate transporter primarily expressed in astrocytes and Bergmann glia that clears glutamate from the synaptic cleft; its transport activity and plasma membrane abundance are regulated by substrate-induced actin-dependent trafficking, PKC-mediated epitope modification, CaMKII-dependent phosphorylation at N-terminal residues (especially T37), SGK/PKB-Nedd4-2-dependent ubiquitination, and GSK3β-mediated phosphorylation; transcription is positively driven by NF-κB (Sp1/Sp3 and USF1 at the core promoter) and negatively by YY1 (with HDAC co-repressors), with upstream signals including glutamate itself (via AMPA receptors), p53, GDNF/neurturin (via PI3K/Src), estrogen, and ATP (via P2X7R/PI3K/Ca2+); disease-associated mutations cause loss-of-function (reduced glutamate uptake and/or impaired K+-retranslocation), dominant-negative multimerization, or altered trafficking; beyond classical neurotransmitter clearance, SLC1A3 activity drives FXYD2/Na+,K+-ATPase surface expression, triggers mTOR/PI3K/AP-1 signaling in glia, fuels aspartate/glutamate-dependent TCA cycle and biosynthetic metabolism in cancer cells under nutrient stress, and coordinates epithelial stem/progenitor cell activation across skin niches via mGluR5 signaling.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"SLC1A3 (EAAT1/GLAST) is a Na+-coupled high-affinity glutamate/aspartate transporter that clears synaptic glutamate in astrocytes and Bergmann glia, sustaining normal Purkinje cell firing and protecting neurons from excitotoxicity [#10, #11]. Transport requires a defined ion-coupling cycle, and a migraine-associated T387P mutation selectively abolishes the K+-bound retranslocation step while preserving Na+-dependent anion currents, defining impaired K+ binding as a discrete transport defect [#6]. Surface abundance and activity are set by an extensive regulatory network: substrate-driven, actin-dependent trafficking to the plasma membrane [#2]; CaMKII phosphorylation of N-terminal T26/T37 [#4]; SGK1/SGK3/PKB-antagonized, Nedd4-2-dependent ubiquitination acting through residue T482 [#1]; PKC-mediated modification of cytoplasmic epitopes [#3]; and GSK3\\u03b2-mediated phosphorylation that suppresses GLAST while stimulating GLT-1 [#21]. Transcription is bidirectionally controlled at a TATA-less core promoter, positively by NF-\\u03baB acting with Sp1/Sp3 and USF1 and negatively by YY1 with HDAC co-repressors, integrating glutamate, cytokine, and growth-factor signals [#16, #17]. Beyond transport, GLAST activity orchestrates downstream membrane and signaling events\\u2014directing FXYD2 to the surface to modulate Na+,K+-ATPase [#9] and triggering Ca2+/PI3K/PKB/mTOR-AP-1 signaling in glia [#18]\\u2014and is co-opted in cancer, where p53 induces SLC1A3 to fuel aspartate/glutamate-dependent TCA cycle and biosynthetic metabolism under nutrient stress [#22, #23]. SLC1A3 also coordinates epithelial stem/progenitor activation across skin niches upstream of mGluR5 [#25]. Loss-of-function, dominant-negative, and gain-of-function missense mutations in SLC1A3 cause episodic ataxia type 6 through partial transport, trafficking, or expression defects to which the cerebellum is acutely sensitive [#0, #5, #7].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Establishing the genomic and promoter architecture of Slc1a3 framed how transcription of the transporter could be controlled.\",\n      \"evidence\": \"Genomic library screening, promoter-luciferase reporters and chromosomal mapping in COS-1 cells\",\n      \"pmids\": [\"8661010\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Did not identify the trans-acting factors binding the CCAAT/GC boxes\", \"Mouse promoter only; human core element unresolved at this stage\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Linking glutamate exposure to up-regulation of GLAST protein showed the transporter is dynamically tuned to substrate load via kainate-type receptor signaling.\",\n      \"evidence\": \"Primary astrocyte uptake assays, Western blot and pharmacological receptor antagonists\",\n      \"pmids\": [\"9051792\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Distinguished post-transcriptional regulation but did not define the molecular trafficking step\", \"Receptor coupling to transporter expression left at the pharmacological level\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Demonstrating that substrate transport itself drives rapid actin-dependent surface delivery of GLAST established a feed-forward mechanism for matching uptake capacity to glutamate availability.\",\n      \"evidence\": \"Astrocyte biotinylation, uptake assays and actin-disruption pharmacology\",\n      \"pmids\": [\"10575016\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Trafficking machinery/adaptors mediating surface delivery not identified\", \"Whether this acute mechanism applies in vivo untested\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Identifying the human EAAT1 core promoter and its Sp1/Sp3 and USF1 factors, and the SGK/PKB-Nedd4-2-T482 ubiquitination axis, defined parallel transcriptional and post-translational set-points for transporter abundance.\",\n      \"evidence\": \"Promoter deletion/EMSA in human astrocytes; Xenopus oocyte electrophysiology with Nedd4-2/SGK/PKB co-expression and T482 mutagenesis\",\n      \"pmids\": [\"14713304\", \"12911626\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether T482 is directly phosphorylated by SGK/PKB not shown\", \"Promoter factor interactions not tested in vivo\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Showing glutamate represses GLAST transcription through Ca2+-permeable AMPA receptors, PKC and c-Jun revealed a negative arm balancing substrate-induced up-regulation.\",\n      \"evidence\": \"Bergmann glia promoter-reporter, uptake and RT-PCR with AMPA/PKC inhibitors\",\n      \"pmids\": [\"12824049\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct promoter element for c-Jun not mapped here\", \"Reconciliation with substrate-induced up-regulation not addressed\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Distinguishing PKC-induced epitope modification from protein loss clarified that acute PKC signaling modifies cytoplasmic regions of GLAST rather than degrading it.\",\n      \"evidence\": \"Astrocyte transport assays, surface biotinylation and flag-tagged GLAST with PKC inhibitor\",\n      \"pmids\": [\"15569258\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific modified residues not identified\", \"Functional consequence of epitope modification beyond a modest activity change unclear\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"The first disease mutation showed EAAT1 loss-of-function and a paralog-specific dominant-negative effect, indicating selective EAAT1-EAAT1 multimerization underlies dominant inheritance.\",\n      \"evidence\": \"Heterologous expression, uptake assays and co-expression dominant-negative tests\",\n      \"pmids\": [\"16116111\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of selective multimerization not resolved\", \"In vivo neuronal consequence not modeled\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Genetic deletion in mice placed GLAST upstream of NMDA receptor overactivation in cerebellar circuits and demonstrated its protective role against excitotoxic Purkinje cell loss.\",\n      \"evidence\": \"GLAST and EAAT4 knockout mice with in vivo electrophysiology, NMDA blockade epistasis and ischemia histology\",\n      \"pmids\": [\"29741614\", \"16647773\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cell-autonomous vs. circuit-level contributions not fully separated\", \"Mechanism of EAAT4 cooperativity unresolved\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Discovering that GLAST activity directs FXYD2 and ASCT2 surface trafficking, and that GDNF/neurturin up-regulate GLAST via PI3K/Src, expanded its role from transporter to organizer of downstream membrane transport and neuroprotection.\",\n      \"evidence\": \"Human fetal astrocyte biotinylation with FXYD2/GS siRNA and transporter block; rat retina with PI3K/Src inhibitors, GLAST siRNA and RGC survival\",\n      \"pmids\": [\"17316900\", \"16516348\", \"18064044\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular link coupling GLAST transport to FXYD2/ASCT2 trafficking unknown\", \"Glutamine-sensing mechanism for ASCT2 induction not defined\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"YY1 was identified as the transcription factor mediating glutamate-induced GLAST repression, providing the trans-acting basis for the negative regulatory arm.\",\n      \"evidence\": \"Bergmann glia promoter-reporter with YY1 site mutation, uptake, RT-PCR and EMSA\",\n      \"pmids\": [\"17394550\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Co-repressor partners not yet defined in this study\", \"Signaling link from glutamate to YY1 binding incomplete\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Defining the P2X7R-driven Ca2+/PI3K-PLC\\u03b3-CaMKII-PKC cascade that destabilizes GLAST mRNA, and the ASK1-dependent stress pathway downstream of GLAST loss, connected extracellular ATP and oxidative/TNF stress to transporter levels and neuronal survival.\",\n      \"evidence\": \"Astrocyte P2X7R knockdown, promoter and RNA-decay assays; GLAST/ASK1 double-knockout glaucoma model\",\n      \"pmids\": [\"20070863\", \"20489729\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"cis-element conferring mRNA instability not mapped\", \"ASK1 pathway placement is epistatic, not biochemically direct on GLAST\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"The Drosophila ortholog established Eaat1 as essential for glutamate homeostasis in locomotor circuits and revealed Fringe/Delta-Notch control of its glial expression developmentally.\",\n      \"evidence\": \"Fly loss-of-function genetics, motor neuron electrophysiology, locomotion assays and Notch pathway epistasis\",\n      \"pmids\": [\"20980602\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Conservation of Notch-driven regulation in mammals untested\", \"Mapping to specific synaptic transmitter clearance steps incomplete\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Showing transport-dependent activation of Ca2+/PI3K/PKB-mTOR-AP-1 signaling cast GLAST as a signaling node, not merely a transporter, in glia.\",\n      \"evidence\": \"Bergmann glia substrate treatments with mTOR phosphorylation, pathway inhibitors and AP-1 reporters\",\n      \"pmids\": [\"21856347\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"How transport flux couples to Ca2+/PI3K signaling mechanistically unknown\", \"Downstream AP-1 target genes not identified\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Demonstrating that GSK3\\u03b2 oppositely regulates GLAST and GLT-1 through differential phosphorylation revealed transporter-selective kinase control.\",\n      \"evidence\": \"COS-7/oocyte expression with activity, surface and 32Pi phosphorylation assays plus GSK3\\u03b2 inhibitors\",\n      \"pmids\": [\"25454285\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"GSK3\\u03b2 phosphosites on GLAST not mapped\", \"Direct vs. indirect phosphorylation not distinguished\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Integrating NF-\\u03baB as a positive and YY1/HDAC as a negative promoter regulator, with manganese and EGF inputs, unified the bidirectional transcriptional control of EAAT1.\",\n      \"evidence\": \"Human astrocyte promoter mutagenesis, YY1 siRNA, NF-\\u03baB inhibition, RT-qPCR and uptake assays\",\n      \"pmids\": [\"26269591\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cooperativity/competition between NF-\\u03baB and YY1 at the promoter not resolved\", \"In vivo relevance of manganese-YY1 axis untested here\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Identifying CaMKII phosphorylation of N-terminal T26/T37 as required for constitutive transport, and a migraine T387P mutation that abolishes K+-retranslocation, refined both the regulatory and ion-coupling mechanisms of EAAT1.\",\n      \"evidence\": \"HEK293T uptake with peptide arrays/GST binding and T37A mutagenesis; mammalian patch clamp with fast substrate application and surface biochemistry\",\n      \"pmids\": [\"27889915\", \"29066757\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether T37 phosphorylation regulates trafficking or intrinsic turnover unclear\", \"Structural basis of K+ binding defect not solved\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Linking p53-induced SLC1A3 to maintenance of TCA cycle flux and biosynthesis under glutamine deprivation, and an upstream role in mGluR5-coordinated skin stem-cell activation, extended its function into tumor metabolic adaptation and tissue regeneration.\",\n      \"evidence\": \"Isotope flux, xenograft growth with SLC1A3 knockdown/overexpression; mouse conditional knockout, fate-mapping and mGluR5 pharmacology\",\n      \"pmids\": [\"30122553\", \"29615452\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct p53 binding to the SLC1A3 locus inferred, not fully demonstrated\", \"Mechanism coupling SLC1A3 transport to mGluR5 signaling undefined\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Showing SLC1A3 drives aspartate/glutamate uptake supporting asparaginase resistance, and that its transport direction in glioblastoma stem cells depends on Na+/K+-ATPase, established context-dependent transporter directionality as a therapeutic vulnerability.\",\n      \"evidence\": \"Functional genetic screen with metabolic profiling and xenografts; GBM stem cells with Na+/K+-ATPase rescue and UCPH-101 inhibition in vivo\",\n      \"pmids\": [\"31523835\", \"30418668\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Tumor-type generality of the directionality switch unclear\", \"Whether transport reversal is exploitable across cancers untested\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Systematic comparison of EA6 mutations showed they produce graded transport, trafficking, and expression defects, explaining the cerebellum's sensitivity to even partial EAAT1 dysfunction.\",\n      \"evidence\": \"Heterologous expression with confocal imaging, Western blot and patch clamp across mutations\",\n      \"pmids\": [\"32741053\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genotype-phenotype severity mapping incomplete\", \"In vivo modeling of individual variants lacking\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Linking reduced EAAT1 function to prolonged Purkinje cell EPSCs and SCA1-like neurodegeneration cast transporter dysfunction as an active driver of cerebellar pathology.\",\n      \"evidence\": \"Bergmann glia optogenetics with Purkinje cell patch clamp and ataxin-1 knock-in comparison\",\n      \"pmids\": [\"33753288\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct biochemical mechanism reducing EAAT1 function during optogenetic activation unresolved\", \"Causal link to human SCA1 inferential\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the diverse phosphorylation, ubiquitination, and trafficking inputs are integrated structurally on a single transporter, and how transport directionality is switched between clearance and release across tissues, remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No structural model integrating regulatory phosphosites\", \"Mechanism determining net uptake vs. efflux in tumor vs. glia undefined\", \"Direct kinase-substrate relationships for several modifications unproven\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [0, 2, 6, 22, 23]},\n      {\"term_id\": \"GO:0140104\", \"supporting_discovery_ids\": [22, 23]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [2, 3, 9, 27]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [27]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [10, 24]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [22, 23]},\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [2, 6]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [16, 17]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"NEDD4-2\", \"SGK1\", \"PKB\", \"CAMK2\", \"GSK3B\", \"FXYD2\", \"TP53\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}